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As part of intracellular copper trafficking pathways, the human copper chaperone Hah1 delivers 
Cu+ to the Wilson’s Disease Protein (WDP) via weak and dynamic protein–protein interactions.  
WDP contains six homologous metal binding domains (MBDs), connected by flexible linkers, 
which all can receive Cu+ from Hah1.  The functional roles of the MBD multiplicity in Cu+ 
trafficking are not well understood.  Building on our previous study of the dynamic interactions 
between Hah1 and the isolated 4th MBD of WDP, here we study how Hah1 interacts with 
MBD34, a double-domain WDP construct, using single-molecule fluorescence resonance energy 
transfer (smFRET) combined with nanovesicle trapping.  By alternating the positions of the 
smFRET donor and acceptor, we systematically probed Hah1–MBD3, Hah1–MBD4, and 
MBD3–MBD4 interaction dynamics within the multi-domain system.  We found that the two 
interconverting interaction geometries were conserved in both intermolecular Hah1–MBD and 
intramolecular MBD–MBD interactions.  The Hah1–MBD interactions within MBD34 are 
stabilized by an order of magnitude relative to Hah1 interactions with the isolated single-MBDs, 
and thermodynamic evidence suggests that Hah1 can interact with both MBDs simultaneously.  
We proposed 2-body and 3-body interaction models based on previously known structures of 
homologous proteins to describe both intermolecular Hah1–MBD and intramolecular MBD–
MBD interactions.  These interaction models and our smFRET results were then used to 
 formulate and quantify a comprehensive Hah1–MBD34 mechanism.  The enhanced interaction 
stability of Hah1 with the multi-MBD system, the dynamic intramolecular MBDMBD 
interactions, and the ability of Hah1 to interact with multiple MBDs simultaneously suggest an 
efficient and versatile mechanism for the Hah1-to-WDP pathway to transport Cu+. 
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CHAPTER 1 
INTRODUCTION 
 
1.1. Weak and Dynamic Protein Interactions Regulate Copper Homeostasis 
 Copper is an essential cofactor for many enzymes, but it must be safely transported and 
regulated in the cell to avoid harmful effects such as oxidative damage.1-3  In humans, the copper 
chaperone, Hah1, specifically delivers Cu+ via weak and dynamic protein interactions to two 
homologous PIB-type ATPases (Figure 1):  the Wilson’s Disease Protein (WDP) and the Menkes’ 
Disease Protein (MNK).4-7  WDP is predominately found in the liver and brain, while MNK is 
generally found in non-hepatic tissues.1,8  Under normal physiological conditions both WDP and 
MNK reside in the trans-Golgi network and use ATP hydrolysis to drive Cu+ translocation from 
the cytosol into the Golgi for later incorporation into various copper enzymes; e.g., WDP 
delivers Cu+ to ceruloplasmin, an enzyme involved in iron homeostasis, while MNK delivers Cu+ 
to tyrosinase, an enzyme involved in the oxidation of phenols.9,10  Under elevated Cu+ stress, 
they relocalize for the export of Cu+ from the cell (Figure 1).11-13  Genetic defects in WDP and 
MNK result in copper toxicity and deficiency disorders respectively.8,14-16 
 Figure 2 presents a schematic of the tertiary structure of WDP and MNK.  Both WDP and 
MNK have six cytosolic N-terminal metal binding domains (MBDs, numbered 1–6 starting from 
the N-terminus) connected by flexible linkers of various lengths.  Interestingly, the number of 
MBDs varies between one and six depending on the organism, with higher organisms generally 
having more MBDs.17  The catalytic core of WDP/MNK consists of eight transmembrane helices 
(TMH) constituting the Cu+ pump, a nucleotide binding (N-) and phosphotase (P-) domain 
involved in the binding and hydrolysis of ATP, and an actuator (A-) domain involved in the 
regulation of Cu+ translocation.13,18   
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Figure 1. After Cu+ enters the cell via Ctr1, Hah1 safely delivers the metal to either WDP or 
MNK.  Under normal physiological conditions, WDP and MNK are located within the TGN 
where they deliver Cu+ to various metalloenzymes.  Elevated levels of Cu+ induce kinase-
mediated phosphorylation and relocalization of WDP/MNK for Cu+ efflux. 
 
 
Figure 2. WDP and MNK contain six homologous MBDs connected by flexible linkers of 
various lengths.  Each MBD can acquire Cu+ from Hah1 via weak and dynamic protein 
interactions.  Cu+ is translocated from the cytosol to the lumen through the TMH using the 
energy from ATP hydrolysis.  The N- and P-domains bind and hydrolyze ATP, while the A-
domain regulates the translocation of Cu+ through the TMH. 
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 Many similarities exist between Hah1 and the MBDs of MNK and WDP.  The individual 
WDP/MNK MBDs and Hah1 are all homologous, each having a βαββαβ protein fold and a 
CXXC Cu+-binding motif.19  They can all bind Cu+, with a similar affinity (~1010 M-1)20 
although recent measurements report binding constants as high as ~1018 M-1.21-23  Under a 
shallow thermodynamic gradient, Hah1 can transfer Cu+ to each MBD with similar efficiency 
(equilibrium constant for Cu+ transfer is ~100).20,24  The Cu+ transfer is mediated by weak and 
dynamic protein interactions, KD ~ μM, consisting of hydrogen bonds, electrostatic interactions, 
and metal-bridging of two proteins’ CXXC motifs.4,6,7,25-28  This is illustrated by the NMR 
structure of Hah1 interacting with the 1st MBD of MNK (Figure 3). 
 
 
Figure 3. NMR structure (PDB code 2K1R)29 of the interaction between Hah1 (red) and MNK1 
(green).  This weak interaction is mediated by hydrogen bonding and electrostatic interactions.  
The Cu+ transfer occurs via a 3-coordinate Cu+–thiolate intermediate which bridges the two 
proteins’ CXXC motifs. 
 
 Despite the many similarities among the MBDs, various differences exist, which perhaps 
define their differences in functional roles. These differences include electrostatic potentials, 
locations within the N-terminal tail, ability to re-orient with regard to the adjacent linkers, and 
complex formation with other MBDs or Hah1.30-33  A combination of yeast two-hybrid assays6,34 
Hah1MNK1
Cu+
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and NMR studies24,31,35,36 have shown that, in general, Hah1 preferentially interacts with MBDs 
1–4 over MBDs 5–6.  Further, yeast complementation37,38 and cellular imaging studies39 showed 
that only MBDs 5–6 were essential for maintaining WDP function.  Taken together, these data 
suggest that MBDs 1–4 may be more important for Cu+ sensing or acquisition via protein 
interactions with Hah1, whereas MBDs 5–6 are more important for Cu+ translocation at the 
trans-Golgi network and WDP/MNK relocalization for Cu+ efflux. 
 After acquisition of Cu+ from Hah1, it is possible that MBDs 1–4 subsequently deliver 
the metal to MBDs 5–6 via intramolecular-interdomain interactions for eventual Cu+ 
translocation through the TMH.31  In this scenario, the MBDs are directly involved in the 
trafficking and delivery of the metal via Hah1–MBD and MBD–MBD interactions.  This direct-
trafficking has been proposed as less likely because no observation of Cu+ transfer from the 
MBDs to the TMH has been observed, and homologous PIB-type ATPases retain their ability to 
receive and translocate Cu+ upon partial or complete removal of their N-terminal MBDs.40  
 Alternatively, the MBDs may behave more like a Cu+ sensor, in which large-scale tertiary 
conformational changes in the N-terminal tail regulate WDP/MNK activity or 
localization.30,33,35,41-43  For the bacterial homolog of WDP, CopA, recent structural studies have 
shown MBD interactions with the N- and A-domains, which may serve as a mechanism for the 
modulation of ATPase activity.44,45  In addition, Cu+-dependent phosphorylation sites located in 
the flexible linkers between MBDs are involved in regulating the cellular localization and 
function of MNK and WDP.46-51  Both Hah1–MBD interactions and MBD–MBD interactions 
would likely change the tertiary structure of the N-terminal tail, and hence modulate the catalytic 
activity for Cu+ translocation or change the accessibility of phosphorylation sites signaling the 
relocalization of WDP/MNK for Cu+ efflux. 
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 In either role, metal trafficking or regulatory, both intermolecular Hah1–MBD 
interactions and intramolecular MBD–MBD interactions are vital to proper WDP/MNK function 
and Cu+ homeostasis in the cell.  Characterizing and understanding these weak and dynamic 
protein interactions remains an important, yet challenging, task.  Surface plasmon resonance 
studies have been used to study the kinetics of these interactions,52,53 but non-specific protein–
surface interactions may perturb the kinetics and the measurements lack structural information.  
NMR,24,29,31,35,36,54-57 X-ray crystallography,25,58-60 protein docking,26 and molecular dynamics 
(MD) simulations28,32,33,61 have provided detailed structural information on the interaction 
interfaces, but can only provide estimates on the interaction thermodynamics and kinetics. 
 
1.2. Single-molecule FRET with Nanovesicle Trapping to Probe Hah1–MBD Interactions 
 To compliment these studies while overcoming some of their limitations, we use single-
molecule fluorescence resonance energy transfer (smFRET)62 in combination with nanovesicle 
trapping63-66 to quantify weak and dynamic Hah1–MBD and MBD–MBD interactions (Figure 4).  
By labeling Hah1 and the MBDs with a smFRET donor-acceptor pair (Cy3-Cy5), we can 
monitor the interaction dynamics of a single pair in real time.  A 532-nm laser excites the donor 
fluorophore using the evanescent wave resulting from total internal reflection (TIR).  The extent 
of energy transfer from the donor to acceptor,    16FRET 01E r r   , is dependent on the distance 
between the donor and acceptor, r, and a constant, r0, which accounts for the spectral overlap, 
quantum yields, and relative orientation of the donor-acceptor pair.67  Because EFRET is sensitive 
to distance changes on the ~nm scale, the smFRET technique can probe protein–protein 
association/dissociation and/or ~nm changes in protein conformation or interaction geometry. 
   The proteins are trapped within surface-immobilized ~100-nm-diameter lipid vesicles, 
which maintain an effective protein concentration of ~μM for a single molecule inside a vesicle, 
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needed for studying weak interactions (KD ~ μM), while also eliminating non-specific protein–
surface interactions. After coating a quartz slide with biotinylated polyethylene glycol (PEG) or 
bovine serum albumin (BSA), the nanovesicles containing the trapped proteins are immobilized 
via biotin-avidin chemistry at ~pM concentrations to allow for the imaging of single 
fluorophores (Figure 4).   
 This single-molecule approach eliminates the need for synchronization and allows us to 
observe interaction intermediates that are otherwise masked in ensemble-averaged 
measurements.  Because we only analyze vesicles containing a single donor-acceptor pair, this 
approach also eliminates homodimeric interactions between two proteins of the same type, which 
are unavoidable in ensemble measurements. 
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Figure 4. Schematic of nanovesicle trapping with smFRET.  The labeled proteins are trapped
within ~100-nm-diameter lipid vesicles to maintain a high Ceff ~ μM needed to study weak
interactions.  Subsequently, the nanovesicles are immobilized on a BSA or PEG-coated quartz
slide using biotin–avidin chemistry at ~pM concentrations, which allows for spatial separation
of the individual fluorophores needed for single-molecule imaging.  The donor fluorophore (Cy3,
green) is excited by TIRF at 532-nm (green background).  Upon protein–protein interaction, the
donor transfers its energy via FRET to the acceptor (Cy5, red).  
 8 
 We have previously used this approach to study interactions between Hah1 and the 
isolated 4th MBD of WDP, denoted MBD4SD (SD: “single domain”), both in the absence (Figure 
5) and presence of Cu+ (Figure 6).68-70   
 We labeled Hah1 and MBD4SD at their C-terminal residues with Cy5 and Cy3, 
respectively (Figure 5A).  By measuring the anticorrelated Cy3 and Cy5 intensities of a single 
Hah1–MBD4SD pair in real time (Figure 5B), we observed three dynamically interconverting 
EFRET states in the absence of Cu+:  EDissoc ~ 0.15, EMid ~ 0.50, and EHigh ~ 0.80.  Here, we 
approximate EFRET as ICy5/(ICy5 + ICy3), where ICy5 and ICy3 represent the intensities of Cy5 and 
Cy3, respectively.  We assigned the EDissoc observable to the dissociated state, Hah1 + MBD4SD, 
due to its  relatively low value (~0.15), which is in agreement with that observed in control 
measurements where free Cy3 and Cy5 molecules are co-trapped.66  We assigned the EMid and 
EHigh observables to two Hah1–MBD4SD interaction geometries, denoted 1Hah1–MBD4SD and 
2Hah1–MBD4SD, respectively.   
 As shown in Figure 5B, the dwell times, τDissoc, τMid, and τHigh of EDissoc, EMid, and EHigh, 
respectively, can be pooled from many Hah1–MBD4SD pairs to examine their respective 
distributions (Figure 5C).  Fitting each distribution with a single-exponential decay function 
gives the average lifetimes of each EFRET state, Dissoc , Mid , and High .  Based on our assignments 
of the chemical species to each EFRET state, we have presented a kinetic mechanism describing 
the Hah1–MBD4SD interactions (Figure 5D).  From the average lifetimes (Figure 5C) and the 
relative transition frequency to each state, we can extract all six kinetic rate constants (Figure 
5E).66,69  The rates of association (k1 and k2) are ~105 M-1 s-1, while the rates of dissociation (k-1 
and k-2) and interconversion (k3 and k-3) are all ~1 s-1.  From the respective ratios of the rate 
constants, we’ve also quantified the dissociation constants for each interaction complex (KD1 and 
KD2) which are both ~100 μM, and equilibrium of interconversion (K3 ~ 1) as reported in Figure 
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5F.  The stabilities of 1Hah1–MBD4SD and 2Hah1–MBD4SD can also be quantified from the 
Gaussian area ratios of EMid/EDissoc and EHigh/EDissoc respectively obtained from the compiled 
EFRET distribution of many interacting pairs (Figure 6A).  These area ratios yield dissociation 
constants KD1 = 7 ± 6 μM and KD1 = 9 ± 7 μM, which are in agreement with those obtained from 
the kinetic analysis (Figure 5F).   
 In the presence of varying stoichiometric equivalents of Cu+, we still observed three 
dynamically interconverting EFRET states, which have the same EFRET values within experimental 
error as EDissoc, EMid, and EHigh.70  The two interaction geometries, 1Hah1–MBD4SD and 2Hah1–
MBD4SD, are therefore retained regardless of the Cu+ stoichiometry.  However, the stabilities the 
interaction geometries do change depending on the stochiometric amount of Cu+ (Figure 6).  
Upon addition of 1 equivalent of Cu+ per protein pair, both 1Hah1–MBD4SD and 2Hah1–MBD4SD 
interactions are stabilized slightly by a factor of ~1.3 (Figure 6B).  We attributed this 
stabilization to metal-bridging of the two CXXC motifs,4,6,7,25-28 similar to that observed in the 
Hah1–MNK1 complex (Figure 3).  The distance between the donor and acceptor labeling sites in 
the Hah1–MNK1 structure, ~5 nm, is indeed in agreement with our measured EMid ~ 0.50 
(possible interaction geometries corresponding to EHigh will be subsequently discussed in Chapter 
4, Section 4.1).  Under excess equivalents of Cu+ (Figure 6C and D), the CXXC motifs of both 
Hah1 and MBD4SD become fully metallated, which disrupts the metal-bridging and destabilizes 
both interaction geometries. 
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Figure 5. (A) Cy5-Hah1 + Cy3-MBD4SD labeling scheme and corresponding (B) smFRET 
trajectory. The lighter colors show the original fluorescence intensities (light green for Cy3 and 
light red for Cy5) and corresponding EFRET (light grey) while the darker colors (dark green for 
Cy3, dark red for Cy5, and black for EFRET) represent data subjected to non-linear forward-
backward filtering (Chapter 2, Section 2.9). Three dynamically interconverting EFRET states are 
apparent:  EDissoc, EMid, and EHigh with dwell times τDissoc, τMid, and τHigh, respectively. (C) The 
dwell time distributions of τDissoc, τMid, and τHigh for hundreds of interacting pairs can be fit with a 
single-exponential decay function to obtain the average dwell times, Dissoc , Mid , and High . (D) 
Kinetic mechanism for Hah1–MBD4SD interactions in the absence of Cu+:  EDissoc contains the 
dissociated state, Hah1 + MBD4SD. EMid and EHigh contain two Hah1–MBD4SD interaction 
geometries, denoted 1Hah1–MBD4SD and 2Hah1–MBD4SD, respectively. (E) Rate constants 
computed from Dissoc , Mid , and High  and the ratio of transitions to each state. (F) Dissociation 
constants, KD1 and KD2, for 1Hah1–MBD4SD and 2Hah1–MBD4SD, respectively, and equilibrium 
of interconversion, K3, as computed from the respective ratios of the rate constants. 
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Figure 6. Compiled EFRET distributions for Cy5-Hah1 + Cy3-MBD4SD in (A) the absence of Cu+ 
(apo), and in the presence of (B) 1, (C) 4, and (D) 6 equivalents of Cu+ per protein pair. The 
distributions were fit globally by sharing the Gaussian peak positions and widths of each EFRET 
state. (F) The EMid/EDissoc and EHigh/EDissoc Gaussian area ratios are plotted with increasing 
equivalents of Cu+ to assess the relative stabilities of the interaction complexes.   
 
 We hypothesized that multiple interaction geometries increase the probability of forming 
a complex for Cu+ transfer.  If only one interaction geometry is productive for Cu+ transfer, then 
the presence of this additional geometry increases the overall rate of association and provides an 
alternate pathway to the productive complex via interconversion.  Additionally, the two 
interaction geometries may have distinct interfaces which allow for Hah1 to interact with 
multiple MBDs simultaneously, where concerted motions among the MBDs may facilitate the 
copper trafficking process.  The latter possibility provides a motivation for studying the 
interaction dynamics of Hah1 with a multi-MBD system of WDP.  
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1.3. Probing Hah1–MBD and MBD–MBD Interactions within a Multi-MBD Construct 
 Here we seek to understand Hah1WDP interactions in the context of WDP’s multi-MBD 
structure, using a WDP construct containing its 3rd and 4th MBDs, MBD34.  We have 
systematically probed Hah1–MBD3, Hah1–MBD4, and MBD3–MBD4 interactions using a 
series of smFRET labeling schemes, which are described in the following chapters.  Note that we 
use the terms “MBD3” and “MBD4” to refer to the respective MBDs within the multidomain 
MBD34 construct.  To probe whether Hah1MBD interactions are influenced by the presence of 
additional MBDs, we compare Hah1–MBD4SD vs. Hah1–MBD4 interactions.  To probe whether 
Hah1 interacts preferentially with certain MBDs, we compare Hah1–MBD4 vs. Hah1–MBD3.  
To understand intramolecular-interdomain interactions between MBDs and how they are coupled 
to intermolecular interactions with Hah1, we have studied the MBD3–MBD4 interactions both in 
the absence and presence of Hah1.  To probe what role multiple MBDs play during the 
trafficking of Cu+, we have studied the Cu+-dependence of Hah1–MBD4 interactions.  Finally, 
we propose a mechanism for the Hah1–multi-MBD interactions considering our smFRET results 
in conjunction with proposed protein interaction models based on previous structural data.  After 
quantitative analysis of the interaction thermodynamics, the functional implications of this 
mechanism for Cu+ trafficking are subsequently discussed.  
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CHAPTER 2 
EXPERIMENTAL METHODS 
 
2.1. Protein Construct Design and Structure 
 The pET-21b(+) Hah1 and pET-32 Xa/LIC MBD34 plasmids were obtained from Amy 
Rosenzweig’s Lab at Northwestern University.  To ensure site-specific labeling by fluorescent 
probes, all native cysteines, apart from those located in the CXXC Cu+-binding motif, were 
mutated to serines.  For Hah1, this included C41S, and for MBD34, these were C71S, C124S, 
and C197S.  Subsequently, a cysteine residue was introduced at a desired location for labeling 
with a fluorescent probe via maleimide chemistry.  This additional labeling cysteine was the C-
terminal C69 in Hah1, C206 at the C-terminus in the MBD34L4 construct, D95C in the MBD34L3 
construct, and both D95C and C206 in the MBD34L34 construct.  The “L4,” “L3,” and “L34” 
superscripts indicate the labeling cysteine is on MBD4, MBD3, or both MBD3 and MBD4, 
respectively.  In all MBD34 constructs, the Cu+-binding cysteines in the CXXC motif of MBD3 
were mutated to alanines (i.e., C34A and C37A) to study the Cu+-dependence of MBD4 
exclusively.  The locations of the Cu+-binding motifs, cysteine-to-serine mutations, and labeling 
sites are annotated within the structure of Hah1 (Figure 7A) and MBD34 (Figure 7B).  Site-
directed mutagenesis was performed in the Novablue (Novagen) or DH5α (Invitrogen) cloning 
strain for MBD34 and Hah1 constructs, respectively. All mutations were confirmed by DNA 
sequencing at the Cornell University Life Sciences CLC Genomics Facility.  The distribution of 
linker distances from the 20 NMR structures of MBD34 is plotted in Figure 7C, giving an 
average distance of between the MBD’s of ~7 nm.   
 14 
0 3 6 9 12
0
2
4
 
 
Linker Distance (nm)
O
cc
ur
re
nc
e
Average ~ 7 nmC
C124S
C71S C197S
D95C
C206
C34A
C37A
MBD3
MBD4
~ 7 nm
C136C139
N-terminus
C-terminus
B
A Hah1
C15
C12C41S
C69
C-terminus
N-terminus
O
cc
ur
re
nc
e
 
Figure 7. (A) Structure of Hah1 (2K1R)29 and (B) representative structure of 
MBD34 (2ROP)57 showing amino acids of interest as spheres.  The CXXC or 
AXXA motifs are shown in red, cysteine-to-serine mutations in purple, and 
labeling residues in green.  The full structure containing the linker region was 
provided by Dr. Francesca Cantini (Center for Magnetic Resonance, University of 
Florence).  (C) Distribution of the linker distances in MBD34, as measured 
between the α-carbons of L93 and C124.  The average distance between MBD3 
and MBD4 is ~7 nm.  
 
2.2. Protein Expression, Purification, and Characterization 
 All proteins were expressed and purified as described previously.68,71  Briefly, the pET-
21b(+) Hah1 plasmid was transformed into the BL21(DE3) expression strain (Novagen) and 
grown to an optical density at 600 nm of 0.8–1.1 before a 3 hr induction with 1 mM isopropyl-β-
D-thiogalactopyranoside (IPTG, US Biological).  Cells were harvested by centrifugation, re-
suspended, and lysed via multiple freeze-thaw cycles in 20 mM MES (US Biological), pH 6.0 
buffer containing 1 mM EDTA (Fisher).  The filtered lysate was purified through anion exchange 
(HiTrap Q HP), cation exchange (HiTrap SP HP), and gel filtration (Superdex 200 Prep Grade) 
columns using FPLC (Amersham Biosciences, GE Healthcare).  For the ion exchange columns, 
 15 
the loading buffer was 20 mM MES, pH 6.0 and the elution buffer was the same with the 
addition of 1 M NaCl.  The gel filtration column was run on the protein pre-reduced with 1 mM 
tris(2-carboxyethyl)phosphine (TCEP, Sigma) using 20 mM MES, 150 mM NaCl, pH 6.0 buffer. 
 The pET-32 Xa/LIC MBD34 plasmids were transformed into the BL21(DE3)pLysS 
expression strain (Novagen) and grown to an optical density at 600 nm of 0.8–1.1, followed by a 
3 hr induction with 0.9 mM IPTG.  The cells were harvested via centrifugation, re-suspended, 
and lysed via stirring at room temperature for 30 min in 50 mM HEPES (US Biological), 500 
mM NaCl, 30 mM imidazole, 5% glycerol, pH 7.5 buffer containing an EDTA-free protease 
inhibitor mini-tablet (Roche).  The MBD34 constructs contained multiple tags at the N-terminus, 
including a HisTag which allowed for the purification of the protein with a Ni2+ column (HisTrap 
HP), using the lysis buffer for loading and a linear gradient to 300 mM imidazole, pH 7.5 to elute 
the sample (Buffer B).  After imidazole removal via buffer-exchange to 50 mM HEPES, 500 mM 
NaCl, 5% glycerol, pH 7.5 (Buffer A), 1 unit of Factor Xa (EMD Biosciences) per 100 μg 
protein was used to cleave the N-terminal purification tags.  After 16 hrs at room temperature, 
the Factor Xa cleavage reaction was stopped by the addition of 1 mM phenylmethylsulfonyl 
fluoride (PMSF, Sigma).  The cleaved protein was then further purified through a Ni2+ column 
with Buffer A as the loading buffer and Buffer B as the elution buffer, followed by a gel filtration 
column with Buffer A on the protein pre-reduced with 1 mM TCEP. 
 The purities of all protein samples were confirmed using SDS-PAGE (>95%).  Their 
identities were further confirmed using mass spectrometry (MALDI) at the University of 
Michigan Protein Structure Facility:  21,453 ± 21 Da (expected 21,453 Da) for MBD34L4, 21,335 
± 21 Da (expected 21,315 Da) for MBD34L3, and 21,408 ± 21 Da (expected 21,425 Da) for 
MBD34L34. The purity and identity of Hah1 was previously confirmed.68 
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2.3. Fluorescent Labeling, Purification, and Characterization 
 The labeling reactions were typically performed on the scale of 400–800 μL at a 
concentration of 0.5 mM protein in 100 mM phosphate, pH 7.0 buffer.  The reaction vial was 
flushed with nitrogen after each step to remove oxygen.  After reducing the protein with 10 
equivalents of TCEP for 1 hr at room temperature, the cysteines in the CXXC motifs were 
protected by the addition of 3–6 equivalents of [Cu(CH3CN)4]PF6 (Sigma), pre-dissolved in a 
50% aqueous solution of acetonitrile.  After 1 hr, the targeted cysteine was fluorescently labeled 
by adding 4–6 equivalents of Cy3- or Cy5-maleimide (GE Healthcare), pre-dissolved in 
anhydrous dimethylsulfoxide.  For the labeling of the MBD34L34 construct, Cy3- and Cy5-
maleimide were added simultaneously as a 1:1 mixture.  The labeling reaction was incubated at 
room temperature for 4 hrs, and overnight at 4 °C. 
 After quenching the excess maleimide dye with ~7 equivalents β-mercaptoethanol (βME, 
Sigma), the unreacted dye was removed using gel filtration (Superdex Peptide HR 10/30, GE 
Healthcare) with 60 mM MES, 20 mM βME, pH 6.0 buffer for Hah1, or with 50 mM HEPES, 20 
mM βME, pH 7.5 buffer for the MBD34 labeling reactions.  The negative charge on the 
fluorescent dyes allowed for the separation of labeled from unlabeled species using anion 
exchange (Tricorn MonoQ 5/50 GL, GE Healthcare) to a purity greater than 95%.  The anion 
exchange column was run with the same buffer used for the dye removal, and eluted with a 
gradient to this buffer containing 1 M NaCl. 
 The labeling stoichiometry and specificity were determined by mass spectrometry.  The 
Hah1 construct is mono-labeled specifically at the C-terminus by Cy5 as reported previously.68  
The MBD34L4 and MBD34L3 proteins were confirmed to be mono-labeled with Cy3 by MALDI:  
22,181 ± 22 Da (expected 22,205 Da) for Cy3-MBD34L4, and 22,083 ± 22 Da (expected 22,087 
Da) for Cy3-MBD34L3. The MBD34L34 construct was found to be double-labeled with a Cy3 and 
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a Cy5 using LC-MS:  22,969 ± 2 Da (expected 22,968 Da).  Although likely present, the 
MBD34L34 protein containing two Cy3 or two Cy5 labels was not detected by LC-MS.   
 The Cy3-MBD34L4, Cy3-MBD34L3, and Cy3Cy5-MBD34L34 proteins were found to be 
labeled specifically at their targeted cysteines by analyzing the masses of the trypsin (Roche) 
digested fragments via LC-MS.  For Cy3-MBD34L4, we observed the labeling fragment 
containing C206-Cy3 (3,403 ± 1 Da, expected 3,405 Da).  For Cy3-MBD34L3, the labeling 
fragment containing C95-Cy3 is 2,238 ± 1 Da (expected 2,238 Da).  For Cy3Cy5-MBD34L34, the 
labeling fragments are those containing C95-Cy3 (2,237 ± 1 Da, expected 2,238 Da), C95-Cy5 
(2,263 ± 1 Da, expected 2,264 Da), C206-Cy3 (3,403 ± 1 Da, expected 3,405 Da), and C206-Cy5 
(3,429 ± 1 Da, expected 3,431 Da).  In all MBD34 constructs, the digested fragments containing 
the CXXC Cu+-binding motif were found to be unlabeled (6,503 ± 1 Da, expected 6,506 Da).  
The complete protection of the CXXC motif from maleimide labeling by Cu+ also confirmed that 
each mutant protein retained its Cu+ binding capability. 
 
2.4. Cu+ Removal 
 The Cu+ was subsequently removed from the proteins by repeated overnight incubations 
with 5000 equivalents of bicinchoninic acid (BCA, Sigma), followed by removal of excess BCA 
and BCA-chelated-Cu+ via ultracentrifugal buffer exchange (using Amicon ultracentrifugation 
filters with molecular weight cut-offs of 5 kDa for Hah1 and 10 kDa for MBD34).  The 
incubation-removal process was repeated 5–8 times, and the samples were checked for copper 
content using the BCA copper quantification assay.72  In all cases, the apo samples were found to 
have a Cu+-to-protein ratio of less than 0.04 (the detection limit of BCA copper assay is ~2 M).  
The large excess of BCA needed to completely remove Cu+ from the labeled proteins (25,000–
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40,000 equivalents) again confirmed the retention of each proteins’ strong Cu+-binding 
capabilities. 
 
2.5. Nanovesicle Trapping 
 A detailed description of our experimental protocol using nanovesicle trapping in 
combination with smFRET has been reported previously.66,68 To trap the proteins inside lipid 
nanovesicles, a sample solution containing 3 μM of each labeled protein, 15 μM TCEP, 2 mM 
Trolox, and the appropriate amount of  [Cu(CH3CN)4]PF6 in 60 mM MES, 110 mM NaCl, pH 
6.0 buffer (Buffer W) was added to a lipid film containing L-α-phosphatidylcholine (Egg-PC, 
Avanti Polar Lipids) mixed with 1% 1,2-dipalmitoyl-sn-glycero3-phosphoethanolamine-N-(cap 
biotinyl) (16:0 biotinyl-cap-PE, Avanti Polar Lipids).  For the experiment involving Cy3Cy5-
MBD34L34 in the presence of excess Hah1, 60 μM of unlabeled Hah1 (20 equivalents over 
Cy3Cy5-MBD34L34) was also present within the hydrating sample along with 1 mM TCEP to 
ensure sufficient reduction.  The final concentration of Egg-PC after hydration was 5 mg/mL, 
and that of biotinyl-cap-PE was 0.05 mg/mL.  After hydrating the lipids for 1 hr at room 
temperature, the sample was passed through a polycarbonate membrane with a 100-nm pore size 
~53 times using a mini-extruder (Avanti Polar Lipids) to make mono-dispersed 100-nm-diameter 
lipid vesicles. 
 
2.6. Single-molecule FRET Experiments 
 A homemade quartz flow cell used for single-molecule total internal reflection 
fluorescence (TIRF) imaging was washed with Buffer W and incubated with 1 mg/mL 
biotinylated-albumin (Sigma) for 45 min, followed by incubation with 0.2 mg/mL Neutravidin 
(Invitrogen) for 15 min.  After washing the flow cell with excess Buffer W, the sample 
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containing the proteins trapped in the biotinylated-nanovesicles was incubated at ~30 pM for 5–
15 min.  The sample incubation time was adjusted depending on the observed density of 
fluorophores to ensure spatial separation of the nanovesicles.  The non-immobilized nanovesicles 
were washed out with excess Buffer W, and an oxygen scavenging system in Buffer W, 
supplemented with 2 mM Trolox, was used for the TIRF imaging.  We found that partially 
oxidized Trolox (~6%) prepared before the experiment by brief UV-illumination was critical for 
maintaining the photostability of Cy3 and Cy5.73  The oxygen scavenging system consisted of 
either 0.2 mg/mL glucose oxidase (Sigma), 0.05 mg/mL catalase (Sigma or Roche), and 4% 
(w/v) (+)-D-glucose (Sigma) (aka the “GODCAT” system) or 50 nM protocatechuate-3,4-
dioxygenase (PCD, Sigma) with 2.5 mM protocatechuic acid (PCA, Sigma).  The GODCAT 
system was refreshed in 30-min intervals to maintain pH stability,74 while the PCD-PCA system 
was refreshed every 3 hrs.75 
 The flow cell was mounted on a modified IX71 Olympus microscope76 where Cy3 
fluorophores were excited using prism-type TIRF across a 68 × 137 μm2 area, with a depth of 
penetration of ~200 nm using a circularly-polarized 532-nm laser (CrystaLaser) at a power of a 
few mW.  The fluorescence emission of both Cy3 and Cy5 were collected through a 60×, NA = 
1.2, water-immersion objective (Olympus) and passed through a Dual-View system (Optical 
Insights) to separate (635DCXR Dichroic, Chroma) and project the Cy3 fluorescence (filtered by 
HQ580-60m, Choma) and Cy5 fluorescence (filtered by HQ660LP, Chroma) onto each half of an 
EMCCD camera (Andor iXon).  Before entering the Dual-View, the laser light was rejected 
using a HQ550LP filter (Chroma).  Images of Cy3 and Cy5 fluorescence intensities were 
collected every 50–100 ms for ~2.5 min using Andor iQ software.  After 2 min, Cy5 
fluorophores were excited directly using a 637-nm laser (CrystaLaser) to check if additional Cy5 
fluorophores were present within the nanovesicle.  The background-subtracted integrated 
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intensities (over a ~2 × 2 μm2 area) of single Cy3 and Cy5 fluorophores were extracted for each 
image using a custom-written IDL program to obtain single-molecule fluorescence intensity 
trajectories. 
 
2.7. Protein–Dye and Protein–Lipid Interaction Controls 
 To ensure that the labeled proteins are not interacting with the dyes, we performed a 
control experiment in which Cy3-MBD34 was cotrapped with free Cy5.  A single anticorrelated 
photobleaching event was observed within an imaging area of 46,720 μm2, whereas typically 
several hundred such events were observed over this area when Cy5-Hah1 is cotrapped with 
Cy3-MBD34.  A similar experiment cotrapping Cy5-Hah1 with free Cy3 was performed 
previously, also showing negligible protein–dye interactions.66,68 
 To test whether the proteins were significantly interacting with the lipids within the 
nanovesicle, we coated the quartz slide in the flow cell with Egg-PC and subsequently flowed in 
~nM concentrations of Cy3-MBD34.  We only observed a few tens of molecules immobilized as 
compared with over 1000 immobilized molecules observed during biotin-avidin specific 
immobilization.  Although this number is slightly greater than that observed in the case of Cy5-
Hah1,68 the non-specific MBD34–EggPC interactions are still relatively infrequent (~6%) and 
are therefore likely to have a minimal contribution to the protein interaction dynamics.  
 
2.8. Nanovesicle Trapping Probabilities 
 Under direct laser excitation, the number of fluorophores present within each vesicle can 
be determined by counting the number of photobleaching steps.  In several control experiments, 
we imaged both Cy3 and Cy5 with simultaneous 532-nm and 637-nm laser excitation to 
determine how many molecules were trapped in each vesicle.  The vesicle occupancy and 
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colocalization probabilities of Cy5-Hah1 and Cy3-MBD34 were found to be similar to that 
observed in our previous study.66,68  The majority of the vesicles (86%) only contained one 
molecule, either Cy3- or Cy5-labeled protein, while only 5% contained one Cy3 and one Cy5 
colocalized.  The probability of cotrapping two Cy5-Hah1 molecules with one Cy3-MBD34 was 
small (0.2%), only ~4% relative to the one-to-one Cy3-Cy5 population and thus negligible.  
During our normal smFRET experiments, as mentioned previously, we further minimized this 
probability by rejecting trajectories showing additional Cy5 photobleaching events upon 637-nm 
laser excitation. 
 
2.9. Single-molecule FRET Data Analysis 
 Only trajectories that showed Cy3-Cy5 anticorrelated intensity fluctuations followed by 
single-step photobleaching events in both channels were analyzed.  The extent of energy transfer 
from the donor to acceptor, or FRET efficiency, EFRET, was approximated as ICy5/(ICy3 + ICy5), 
where ICy3 and ICy5 represent the intensities of Cy3 and Cy5 respectively.   
 To remove noise and aid in the resolution of EFRET states, ICy3 and ICy5 were filtered using 
a nonlinear forwards-backwards algorithm77-79 with filtering parameters M = 3, p = 20, K = 5, 
where M is the window size, p is an exponential weighting factor, and K is the number of 
forward-backward predictors.  Each intensity (either Cy3 or Cy5), I, for frame number i was 
filtered according to 
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where ˆ ( )fkI i  is the forward predictor (found by averaging M − 1 data points before i) and ˆ ( )bkI i  is 
the backward predictor (found by averaging M − 1 data points after i).  ( )kf i  and ( )kb i  represent 
the forward and backward weighting factors, respectively, given by 
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The value of M was chosen to be approximately half of the shortest average waiting time, to 
avoid “smoothing” transitions between EFRET states.  Dwell time analysis of each EFRET state 
(described in Chapter 3, Section 3.4) before and after filtering resulted in identical average 
lifetimes; thus, this value of M did not “smooth” the majority of the transitions.  The values of K 
and p were typical values recommended by the developers of the algorithm.77 This nonlinear 
filter was shown to be effective in reducing noise in single-molecule trajectories.78,79 
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CHAPTER 3 
PROBING HAH1–MBD34 INTERACTIONS WITH SINGLE-MOLECULE FRET 
 
3.1. FRET Labeling Schemes for Dissecting Protein Interactions   
 We used three donor-acceptor (Cy3-Cy5) FRET labeling schemes to dissect the inter- and 
intra-molecular interactions among Hah1 and the two MBDs of MBD34. To directly observe 
Hah1MBD4 interactions, we labeled Hah1 at its C-terminus (i.e., C69) with Cy5, and MBD4 at 
its C-terminus (i.e., C206) with Cy3 (Figure 8A); we refer to this MBD34 construct as “Cy3-
MBD34L4,” where L4 denotes that the label is on MBD4. To directly observe Hah1MBD3 
interactions, we labeled MBD3 at its C-terminus (i.e., C95) with Cy3 (Figure 8D); we refer to 
this MBD34 construct as “Cy3-MBD34L3.” To observe intramolecular-interdomain MBD3–
MBD4 interactions within MBD34, we labeled these two domains at their respective C-terminals 
(i.e., C95 and C206) with the Cy3-Cy5 pair (Figure 8G); the Cy3 or Cy5 can be attached to 
either of the two cysteines; we refer to this double-labeled MBD34 construct as “Cy3Cy5-
MBD34L34.”  This double labeling also generated MBD34 molecules that contain two Cy3 or 
two Cy5 probes; these could be easily differentiated in our smFRET experiments and were 
excluded in our data analysis (Chapter 2, Section 2.9). In all MBD34 constructs, the cysteines in 
the CXXC motif of MBD3 were mutated to alanines to remove MBD3’s Cu+-binding capability, 
so Cu+-transfer could only occur between Hah1 and MBD4. 
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Figure 8. (A) Cy5-Hah1 + Cy3-MBD34L4 labeling scheme to probe Hah1–MBD4 interactions, 
(B) corresponding  smFRET trajectory, and (C) two-dimensional (2-D) histogram of the average 
lower vs. average higher EFRET state for 226 pairs.  (D) Cy5-Hah1 + Cy3-MBD34L3 labeling 
scheme to probe Hah1–MBD3 interactions, (E) corresponding smFRET trajectory, and (F) 2-D 
EFRET histogram for 285 pairs.  (G) Cy3Cy5-MBD34L34 labeling scheme to probe MBD3–MBD4 
interactions, (H) corresponding smFRET trajectory, and (I) 2-D EFRET histogram for 248 
molecules. In all trajectories, the light colors show the original fluorescence intensities and 
corresponding EFRET while the darker colors represent data subjected to non-linear forward-
backward filtering (Chapter 2, Section 2.9). For each 2-D histogram, three populations are 
observed, corresponding to ELow-EMid, ELow-EHigh, and EMid-EHigh combinations.  The 1-D 
projections of the histograms and their Gaussian resolution allow for the determination of the 
center EFRET values. 
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3.2. Observation of Dynamic Protein–Protein Interactions in the Absence of Cu+.  
 By trapping two protein molecules labeled with the Cy3-Cy5 pair or a single protein 
labeled with this pair within an immobilized nanovesicle and measuring their smFRET, we first 
studied the dynamic interactions between Hah1 and MBD34 and between the two domains of 
MBD34 in the absence of Cu+. 
 For all labeling schemes we observed anticorrelated Cy3-Cy5 donor-acceptor 
fluorescence intensity fluctuations, reporting the dynamic intermolecular Hah1–MBD (Figure 
8B, E) and intramolecular MBD3–MBD4 interactions (Figure 8H).  In each case, three 
interconverting EFRET states are apparent, at EFRET ~0.2, ~0.5, and ~0.8. We refer to these 
respective states as L4LowE , 
L4
MidE , and 
L4
HighE  for the Cy5-Hah1 + Cy3-MBD34
L4 labeling scheme; 
L3
LowE , 
L3
MidE , and 
L3
HighE  for the Cy5-Hah1 + Cy3-MBD34
L3 labeling scheme; and L34LowE , 
L34
MidE , 
and L34HighE  for the Cy3Cy5-MBD34
L34 labeling scheme.   
 Because many smFRET trajectories showed only two EFRET states before Cy3 or Cy5 
photobleached, we pooled data from a few hundred interacting pairs for each labeling scheme 
and examined the 2-dimensional (2-D) histogram of the average lower (either ELow or EMid) vs. 
higher (either EMid or EHigh) EFRET values Figure 8C, F, I).  Three distinct populations are clear in 
each 2-D histogram, whose Gaussian-resolved peak values are L4LowE = 0.26 ± 0.01, 
L4
MidE  = 0.50 ± 
0.01, and L4HighE  = 0.77 ± 0.01 for Cy5-Hah1 + Cy3-MBD34
L4;  L3LowE  = 0.21 ± 0.01, 
L3
MidE  = 0.49 
± 0.02, and L3HighE  = 0.76 ± 0.01 for Cy5-Hah1 + Cy3-MBD34
L3; and L34LowE  = 0.22 ± 0.01, 
L34
MidE  = 
0.50 ± 0.02, and L34HighE  = 0.75 ± 0.01 for Cy3Cy5-MBD34
L34. 
 The large values of EMid and EHigh indicate the formation of intermolecular Hah1–MBD 
or intramolecular MBD3–MBD4 interaction complexes, as the Cy3 and Cy5 labels should be 
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within a few nm from each other.  The significant difference between EMid and EHigh indicates 
that these two EFRET states correspond to two protein interaction geometries, similar to that 
observed in our previous study of Hah1 interacting with the single-domain construct,  
MBD4SD.68 The similarity in the EMid and EHigh values across the three labeling schemes indicates 
that the two interaction geometries are conserved between Hah1–MBD4, Hah1–MBD3, and 
MBD3–MBD4 interactions, consistent with Hah1 and all WDP MBDs being homologous in 
sequence and structure. 
 For the two labeling schemes that probe intermolecular Hah1–MBD interactions, the 
L4
LowE  and 
L3
LowE  states represent the case where the proteins are far apart, yet their EFRET values 
are higher than that of a completely dissociated state, EDissoc = 0.15 ± 0.01, which was 
independently determined in control experiments with vesicles containing free Cy3 and Cy5 and 
in our previous study of Hah1MBD4SD interactions.66,68 Therefore, besides the dissociated 
species, the L4LowE  state must contain Cy5-Hah1 interactions with the unlabeled MBD3 in Cy3-
MBD34L4, and the L3LowE  state must contain Cy5-Hah1 interactions with the unlabeled MBD4 in 
Cy3-MBD34L3; these interactions would give an EFRET ~ 0.22 based on our EFRET vs. distance 
calibration curve (Figure S1A), considering the MBD3-to-MBD4 linker distance of ~7 nm 
(Figure 7C). 
 For Cy3Cy5-MBD34L34, L34LowE  corresponds to the state where MBD3 and MBD4 are 
separate with their linker in an extended conformation (denoted as MBD34ext,); this extended 
conformation was observed in MBD34’s NMR structure (Figure 7B).57 As noted above, the 
average distance between the two domains is ~7 nm in MBD34ext, corresponding to an expected 
EFRET ~ 0.22 (Figure 7C and Figure S1A), consistent with the value of L34LowE .  It is worth noting 
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that L34LowE  also approximates the EFRET value when Cy5-Hah1 interacts with the respective 
unlabeled domain of Cy3-MBD34L4 or Cy3-MBD34L3 (i.e., L34LowE  ≈ L3LowE  ≈ L4LowE ).    
 Combining all above results, we have studied how Hah1 interacts with each MBD within 
the double-domain WDP construct, MBD34, and how the two domains in MBD34 interact with 
each other in the absence of Cu+. Hah1 can interact with each MBD forming two different 
complexes. Correlating with our previous work on Hah1 interaction with MBD4SD,68-70 the 
results show that Hah1 can interact with MBD4 in two geometries in both the single-domain 
MBD4SD and the double-domain MBD34 constructs.  For MBD3, our results represent the first 
direct observation of any complex formation with Hah1. Moreover, we observed two MBD3–
MBD4 interactions with geometries similar to Hah1–MBD interactions; this is the first direct 
observation of intramolecular-interdomain complexes between MBD3 and MBD4. It appears that 
the two interaction geometries are conserved for any pair between Hah1, MBD3, and MBD4, 
which are all homologous to each other. This conservation in interaction geometries indicates 
that Hah1, MBD3, and MBD4 use similar protein surface patches for their interactions. 
 
3.3. Stabilities of Hah1–MBD34 Intermolecular Interactions in the Absence of Cu+.   
 Figure 9B and C show the EFRET distributions from hundreds of smFRET trajectories of 
Cy5-Hah1 interacting with Cy3-MBD34L4 or Cy3-MBD34L3, along with that of Cy5-Hah1 
interacting with Cy3-MBD4SD that we reported previously (Figure 9A).66,68 These EFRET 
distributions can be Gaussian-resolved to individual EFRET states; the relative areas of the 
resolved peaks reflect the relative stabilities of chemical species associated with the EFRET states. 
For Cy5-Hah1 + Cy3-MBD4SD, as determined previously,66,68 the EFRET distribution contains 
three peaks (Figure 9A): EDissoc ~ 0.15, EMid ~ 0.50, and EHigh ~ 0.81, corresponding to the 
dissociated state and the two Hah1MBD4SD interaction complexes, respectively. 
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 For Cy5-Hah1 + Cy3-MBD34L4, we used four Gaussian peaks to resolve the EFRET 
distribution (Figure 9B). Two of them are centered at L4MidE  ~ 0.50 and L4HighE  ~ 0.75, as resolved 
in Figure 8C, which correspond to the complexes between Hah1 and MBD4. For the other two, 
one accounts for the dissociated state (EDissoc), which is centered at ~0.15 as resolved from the 
Cy5-Hah1 + Cy3-MBD4SD EFRET distribution (Figure 9A) and appears as a shoulder in Figure 
9B; the other accounts for the state where Cy5-Hah1 forms complexes with the unlabeled MBD3 
in Cy3-MBD34L4 ( L4LowE   ~ 0.27) as discussed in Section 3.2, and its center was floated in 
Gaussian-resolving the EFRET distribution. Note, EDissoc and L4LowE   are unresolved within the L4LowE  
state in Figure 8C. 
 Similarly, for Cy5-Hah1 + Cy3-MBD34L3, we used four Gaussian peaks to resolve the 
EFRET distribution, centered at EDissoc ~ 0.15, L3LowE   ~ 0.27, L3MidE  ~ 0.50, and L3HighE  ~ 0.75, 
corresponding to the dissociated state, the state where Hah1 interacts with the unlabeled MBD4, 
and the two states where Hah1 complexes with MBD3, respectively (Figure 9C). We shared the 
center positions and widths of these peaks with those for resolving the EFRET distribution of Cy5-
Hah1 + Cy3-MBD34L4 in Figure 9B; this is a valid approximation as the center positions 
determined through the 2-D EFRET analyses are the same within experimental error for Cy5-Hah1 
+ Cy3-MBD34L4 and Cy5-Hah1 + Cy3-MBD34L3 (Figure 8C, F). Furthermore, because EDissoc 
represents the same dissociated state for both Cy5-Hah1 + Cy3-MBD34L4 and Cy5-Hah1 + Cy3-
MBD34L3 labeling schemes, the relative peak area of the EDissoc state is shared between Figure 
9B and C. 
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Figure 9. Compiled EFRET distributions (bin size = 0.03) and corresponding Gaussian fits for (A) 
Cy5-Hah1 + Cy3-MBD4SD, (B) Cy5-Hah1 + Cy3-MBD34L4, (C) Cy5-Hah1 + Cy3-MBD34L3, 
(D) Cy3Cy5-MBD34L34, and (E) Cy3Cy5-MBD34L34 with excess Hah1. The EFRET distributions 
were fitted globally by sharing the center values and widths of each EFRET state.  (F) The area 
ratios of EMid and EHigh states with respect to EDissoc for Cy5-Hah1 + Cy3-MBD4SD, Cy5-Hah1 + 
Cy3-MBD34L4, and Cy5-Hah1 + Cy3-MBD34L3 determined from AC. (G) The area ratios of 
EMid and EHigh with respect to ELow′ for Cy3Cy5-MBD34L34 and Cy3Cy5-MBD34L34 with excess 
Hah1 determined from DE. 
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 The deconvolution of ELow′ from EDissoc in these EFRET distributions allows us to account 
for Cy5-Hah1’s interactions with the unlabeled domain within Cy3-MBD34L4 or Cy3-MBD34L3, 
so that we can quantify the stability of the Hah1–MBD interactions relative to the dissociated 
state EDissoc, given by the peak area ratios in the EFRET distributions. In both Cy5-Hah1 + Cy3-
MBD34L4 and Cy5-Hah1 + Cy3-MBD34L3 labeling schemes, the EMid/EDissoc and EHigh/EDissoc 
area ratios are comparable (Figure 9F), indicating that Hah1–MBD3 and Hah1MBD4 
interactions have similar stabilities. However, compared with Hah1MBD4SD interactions, Hah1 
interactions with MBD4 and MBD3 within MBD34 are both more stable by an order of 
magnitude, reflected by the increase in EMid/EDissoc and EHigh/EDissoc area ratios (Figure 9F). This 
increased stability indicates that there are concerted actions between the two MBDs (and perhaps 
the linker region) in MBD34 that facilitate interactions with Hah1. 
 The similar stability of Hah1–MBD3 and Hah1–MBD4 interactions suggests that Hah1 
does not have a significant preference for interacting with one MBD over the other within the 
double-domain MBD34 construct. This is contrary to previous NMR experiments, which only 
detected Hah1 complex formation with MBD4 and not MBD3 (in the presence of Cu+),24,57 but is 
in agreement with the yeast two-hybrid assay, which also detected Hah1–MBD3 interactions.6 
The comparable complex formation of Hah1 with these MBDs observed here may explain why 
Cu+-loaded Hah1 can fully metallate both MBD3 and MBD4.20,24,57 
 The area percentages (χ) of the EFRET states in the EFRET distributions can be used to 
analyze the population percentages of all complexes. From the Cy5-Hah1 + Cy3-MBD34L4 
EFRET distribution (Figure 9B), the total population percentage of Hah1 in complexes with 
MBD4 is L4Mid  + L4High  = 62 ± 4%. From the Cy5-Hah1 + Cy3-MBD34L3 EFRET distribution 
(Figure 9C), the total population percentage of Hah1 in complexes with MBD3 is L3Mid  + L3High  = 
52 ± 9%. Interestingly, the total population percentage of Hah1 in complexes with either MBD3 
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or MBD4 would then sum to greater than unity (114 ± 10%). This suggests there must be overlap 
(>14 ± 10%) between the population of Hah1 in complexes with MBD3 and that of Hah1 in 
complexes with MBD4. In other words, there must be a population in which Hah1 is in close 
proximity with MBD4 and MBD3 simultaneously, e.g., forming 3-body interactions.   
 In the Cy5-Hah1 + Cy3-MBD34L4 EFRET distribution (Figure 9B), the L4LowE   state 
represents Hah1 interactions with the unlabeled MBD3 in the MBD34ext conformation (as any 
interactions involving MBD4 are contained in L4MidE  or 
L4
HighE ). Its population percentage, 
L4
Low   = 
35 ± 4%, is significantly less than the population percentage of all Hah1 complexes with MBD3 
determined from the Cy5-Hah1 + Cy3-MBD34L3 EFRET distribution ( L3Mid  + L3High  = 52 ± 9%, 
Figure 9C); the difference between the above percentages again indicates that there is overlap 
(17 ± 10%) between the apparent Hah1–MBD3 and Hah1–MBD4 complexes. 
 Similarly, in the Cy5-Hah1 + Cy3-MBD34L3 EFRET distribution (Figure 9C), the L3LowE   
state represents Hah1 interactions with the unlabeled MBD4 in the MBD34ext conformation. Its 
population percentage, L3Low   = 46 ± 9%, is less than the population percentage of all Hah1 
complexes with MBD4 determined from the Cy5-Hah1 + Cy3-MBD34L4 EFRET distribution 
( L4Mid  + L4High  = 62 ± 4%, Figure 9B). In agreement with the analysis above, the difference (16 ± 
8%) again reflects a population overlap in the apparent Hah1–MBD3 and Hah1–MBD4 
complexes. 
 To summarize, the population analysis of Cy5-Hah1 interacting with Cy3-MBD4SD, Cy3-
MBD34L4, and Cy3-MBD34L3 demonstrates that Hah1 interactions with MBDs within the 
double-domain MBD34 construct are significantly more stable than with the isolated MBD4SD. 
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Moreover, Hah1–MBD3 and Hah1–MBD4 interactions have similar stability; and Hah1 can be 
in close proximity to MBD3 and MBD4 simultaneously, with a percentage occurrence of ~16%. 
 
3.4. Timescales of Intermolecular Hah1–MBD34 Interactions in the Absence of Cu+.   
 From the smFRET trajectories (Figure 8B, E, H), we can quantify the stochastic dwell 
times (τLow, τMid, and τHigh) of the three EFRET states (ELow, EMid, and EHigh).  The distributions of 
these dwell times all follow single-exponential decay approximately:  f(τ) = Nexp(–τ/ ), where 
  is a time constant and N is a scaling factor (Figure 10 and Figure S2).   is also equivalent to 
the average of the respective dwell time and represents the apparent lifetime of that EFRET state.  
Table 1 summarizes the apparent lifetimes ( Low , Mid , and High ) of each EFRET state for each 
labeling scheme. 
 For the Cy5-Hah1 + Cy3-MBD34L4 and Cy5-Hah1 + Cy3-MBD34L3 labeling schemes, 
Mid  and High  represent the apparent lifetimes of the interaction complexes between Hah1 and 
MBD4 or between Hah1 and MBD3. Unfortunately, Low  is not the lifetime of the dissociated 
state, as the ELow state in the smFRET trajectories contains contributions from both the 
dissociated state (EDissoc) and the complexes in which Cy5-Hah1 interacts with the unlabeled 
domain in Cy3-MBD34L4 or Cy3-MBD34L3 (i.e., ELow′), as discussed in Sections 3.2 and 3.3. In 
both labeling schemes, the population of ELow′ state is much higher than that of EDissoc, shown by 
the resolved EFRET distributions (Figure 9B, C). Therefore, Low  predominantly represents the 
apparent lifetime of ELow′ for these two labeling schemes. 
 Comparing the apparent lifetimes of Hah1–MBD4 and Hah1–MBD4SD complexes (from 
Cy5-Hah1 interacting with Cy3-MBD34L4 or Cy3-MBD4SD), Mid  is similar in both cases (~0.9 
s), whereas High  is slightly longer for Hah1–MBD4 (~1.1 s) vs. Hah1–MBD4SD (~0.7 s) (Table 
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1). These comparable or slightly longer lifetimes of the Hah1–MBD4 interaction complexes 
cannot account fully for the order-of-magnitude increase in complex stability observed in the 
EFRET distributions (Figure 9F). Therefore, there must be a significant decrease in the lifetime of 
the dissociated state for Hah1 interacting with the double-domain construct MBD34.  This 
decrease in the lifetime of the dissociated state has also been proposed by van Dongen et al. to 
rationalize the increased affinity of Hah1 interacting with a four-domain WDP construct (MBDs 
1–4) as compared with single-isolated MBDs, arising from the presence of multiple binding sites 
for Hah1.34  Unfortunately, we could not directly determine the lifetime of the dissociated state 
due to its minor contribution to the experimental Low . 
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Figure 10. Distributions of the dwell time τLow, τMid, and τHigh from EFRET trajectories of Cy5-
Hah1 + Cy3-MBD34L4.  Bin size = 0.3 s. Solid lines are fits with a single-exponential decay 
function, /( )f Ne    . Here   is the decay time constant, which also represents the average 
dwell time. N is a scaling factor.  This analysis was performed for the dwell times from EFRET 
trajectories for all labeling schemes (Appendix, Section S2).  Low , Mid , and High  represent the 
apparent lifetime of respective states (Table 1).  
 
 
Table 1. The average dwell time (seconds) of each EFRET state 
Experiment Low  Mid  High  
apo Cy5-Hah1 + 
Cy3-MBD4SD 0.97 ± 0.07 0.88 ± 0.05 0.67 ± 0.04 
apo Cy5-Hah1 + 
Cy3-MBD34L4 0.77 ± 0.06 0.95 ± 0.05 1.09 ± 0.06 
+ 1 eqv Cu+ 0.83 ± 0.07 0.85 ± 0.05 0.95 ± 0.05 
+ 2 eqv Cu+ 0.62 ± 0.04 0.44 ± 0.02 0.53 ± 0.03 
+ 4 eqv Cu+ 0.67 ± 0.04 0.43 ± 0.02 0.48 ± 0.02 
apo Cy5-Hah1 + 
Cy3-MBD34L3 0.89 ± 0.06 0.80 ± 0.04 0.69 ± 0.03 
Cy3Cy5-
MBD34L34 0.59 ± 0.03 0.64 ± 0.03 0.61 ± 0.03 
+ Excess Hah1 0.48 ± 0.02 0.38 ± 0.01 0.34 ± 0.01 
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 Comparing the apparent lifetimes of Hah1–MBD4 and Hah1–MBD3 complexes (from 
Cy5-Hah1 interacting with Cy3-MBD34L4 or Cy3-MBD4L3), Mid  and High  are slightly longer 
for Hah1–MBD4 complexes, but are still in similar magnitude (~1 s, Table 1).  This is consistent 
with the similar stabilities of Hah1–MBD4 and Hah1–MBD3 interactions, given by the area 
ratios of their respective EFRET states (Figure 9F).  Their Low ’s are also similar, and mainly 
reflect the lifetimes for Cy5-Hah1 interactions with the respective unlabeled domain within Cy3-
MBD34L4 or Cy3-MBD34L3. 
 In short, here we have examined the apparent lifetimes of the EFRET states for Cy5-Hah1 
interacting with Cy3-MBD4SD, Cy3-MBD34L4, or Cy3-MBD34L3 to assess the kinetic aspect of 
the trends in complex stability for Hah1–MBD4SD, Hah1–MBD4, and Hah1–MBD3 interactions. 
Comparing Hah1–MBD4 vs. Hah1–MBD3 interactions, the apparent lifetimes of the protein 
complexes are similar, consistent with their similar apparent stabilities. However, the apparent 
lifetimes of their complexes are also similar to those of Hah1MBD4SD interactions; therefore, 
the increased complex stabilities in Hah1’s interactions with MBD34 likely come from an 
increase in the rate of protein association, rather than decrease in protein dissociation. 
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3.5. Stabilities and Kinetics of Intramolecular-Interdomain Interactions within MBD34.   
 Using Cy3Cy5-MBD34L34, we observed intramolecular interactions between MBD3 and 
MBD4 (Section 3.2). Besides the extended conformation, MBD34ext (i.e, L34LowE ), two 
intramolecular-interdomain complexes are clear (i.e., L34MidE  and 
L34
HighE ), which interconvert 
dynamically (Figure 8H and I). Scheme 1 presents the simplest kinetic scheme describing these 
intramolecular-interdomain interactions within MBD34. 
 
 
 
1
34 1
1
ext 1
MBD34
MBD34
kK
k
   
 
2
34 2
2
ext 2
MBD34
MBD34
kK
k
   
2
34 3
int 1
3
MBD34
MBD34
kK
k
     
MBD34ext
1MBD34
2MBD34
k3k-3
k1
k-1
k2
k-2
Scheme 1. Kinetic mechanism of the
intramolecular-interdomain interactions between
MBD3 and MBD4.  Rate constants:  k1 = 0.9 ± 0.1
s1, k1 = 0.88 ± 0.09 s1, k2 = 0.79 ± 0.05 s1, k2 =
0.76 ± 0.08 s1, k3 = 0.69 ± 0.03 s1, and k3 = 0.87
± 0.04 s1.  Equilibrium constants:  341K  = 1.0 ± 0.2,
34
2K  = 1.0 ± 0.1, and 
34
intK  = 0.79 ± 0.05.  
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 Accordingly, we used three Gaussian peaks to resolve the EFRET distribution of Cy3Cy5-
MBD34L34 (Figure 9D). They are centered at L34LowE   ~ 0.27, L34MidE  ~ 0.50, and L34HighE  ~ 0.75, 
corresponding to the extended conformation, MBD34ext, and the two intramolecular-interdomain 
complexes, denoted as 1MBD34 and 2MBD34, respectively. The center value and width of the 
L34
LowE   peak were shared with L3LowE   and L4LowE   in Figure 9B and C because the observed EFRET 
for MBD34ext in the Cy3Cy5-MBD34L34 labeling scheme should be similar to Cy5-Hah1 
interacting with the unlabeled domain in Cy3-MBD34L4 or Cy3-MBD34L3.  The center values 
and widths of L34MidE  and 
L34
HighE  were shared with the other distributions as well because the two 
interaction geometries between any pair of Hah1, MBD3, and MBD4 appear conserved as noted 
previously (Section 3.2). Relative to the extended conformation, MBD34ext, the equilibrium 
stability constants of 1MBD34 ( 341K  = 0.6 ± 0.2) and 
2MBD34 ( 342K  = 0.6 ± 0.2) can be obtained 
from the peak area ratios in the Cy3Cy5-MBD34L34 EFRET distribution (Figure 9D and Scheme 
1).  These two intramolecular complexes are approximately equal in stability.  
 To determine the six kinetic rate constants for the intramolecular-interdomain MBD3–
MBD4 interactions (Scheme 1), we used the single-exponential decay constants obtained from 
the τLow, τMid, and τHigh dwell-time distributions, fLow(τ), fMid(τ), and fHigh(τ), along with the 
relative transition frequencies to each state obtained from the Cy3Cy5-MBD34L34 smFRET 
experiment (Figure S2E).  Below, we present the previously derived dwell-time distribution 
functions, fLow(τ), fMid(τ), and fHigh(τ), for a 3-state equilibrium process (equations 1.1–1.3).66,68,69 
      1 2Low 1 2 k kf k k e      (1.1) 
      1 3Mid 1 3 k kf k k e      (1.2) 
      2 3High 2 3 k kf k k e      (1.3) 
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Fitting the distributions of τLow, τMid, and τHigh gives the values of the exponential terms. 
 The relationship between ratio of transition frequencies and the rate constants are as 
follows (equations 2.1–2.3):66,68,69 
 Low Mid 1
Low High 2
N k
N k


  (2.1) 
 Mid Low 1
Mid High 3
N k
N k
 

  (2.2) 
 High Low 1
High Mid 2
N k
N k


  (2.3) 
where Nx→y represents the number of transitions between EFRET states Ex and Ey.  With six 
equations (1.1 – 2.3) and six unknowns (k1, k-1, k2, k-2, k3, and k-3) we can readily solve for all 
rate constants as reported in Scheme 1. 
 The intramolecular-interdomain association rate constants (k1 and k2), the dissociation 
rate constants (k−1 and k−2), and the interconversion rate constants (k3 and k−3) all occur in similar 
timescales, ~1 s−1.  The rate constants also give the equilibrium constants, 341K  = 1.0 ± 0.2, 342K  
= 1.0 ± 0.1, and 34intK  = 1.3 ± 0.3, consistent with those obtained from analyzing the Gaussian-
resolved EFRET distribution (Figure 9D).   
 In the presence of excess unlabeled Hah1, the three EFRET states were still observed for 
Cy3Cy5-MBD34L34, shown by the 2-D EFRET analysis (Figure S3B) and the EFRET distribution 
(Figure 9E). Therefore, the two intramolecular-interdomain complexes of MBD34 still occur in 
the presence of Hah1. However, the apparent stabilities of these three states have changed, 
reflected by the changes in the peak area ratios in the EFRET distribution (Figure 9G), and so have 
the average dwell times of these three states (Table 1). These changes indicate that Hah1 
interacts with MBD34 regardless of its two domains being in the extended conformation or 
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forming intramolecular-interdomain complexes. Particularly, the ability of Hah1 to interact with 
the intramolecular-interdomain complexes of MBD34 indicates that Hah1, MBD3 and MBD4 
can come together to form 3-body interactions, consistent with the population overlap between 
the complexes observed in the Cy5-Hah1 + Cy3-MBD34L4 and Cy5-Hah1 + Cy3-MBD34L3 
experiments (Section 3.3). 
 
3.6. Cu+-Dependence of Hah1MBD34 Interactions.   
 We further investigated the Cu+-dependence of Hah1–MBD34 interactions using the 
Cy5-Hah1 + Cy3-MBD34L4 labeling scheme, which directly probes Hah1MBD4 interactions. 
Cu+-transfer can only occur between Hah1 and MBD4 here because the CXXC Cu+-binding 
motif of MBD3 was mutated to AXXA. The Cu+-dependence of the isolated Hah1–MBD3 
interactions should be minimal, as Hah1 has merely small conformational changes upon Cu+-
binding.80  
 Three apparent EFRET states ( L4LowE , 
L4
MidE , and 
L4
HighE ) are still observed in the presence of 
1, 2, and 4 eqv Cu+ (Figure S3A).  Again, the apparent L4LowE  state contains contributions from 
the dissociated state, EDissoc, and Hah1 interactions with the unlabeled MBD3, L4LowE  .  All three 
EFRET values are similar to those in the absence of Cu+ (Figure 8C), indicating that within our 
experimental limit the Hah1–MBD4 interaction geometries remain largely unchanged by Cu+.   
 Yet, the stabilities and dynamics of the Hah1–MBD4 interactions are dependent on the 
presence of Cu+, as shown by the Gaussian-resolved EFRET distributions and average lifetimes 
(Figure 11). In the presence of 1 eqv Cu+, the L4MidE /EDissoc and 
L4
HighE /EDissoc area ratios in the 
EFRET distribution and the lifetimes of L4MidE  and 
L4
HighE  do not change much compared with those 
of the apo protein interactions (Figure 11D, E). Therefore, Hah1 interactions with MBD4 are 
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unperturbed by 1 eqv Cu+. This is in contrast to the Cu+-dependence of Hah1–MBD4SD 
interactions, which showed a factor of ~1.3 stabilization at 1 eqv Cu+; this stabilization was 
attributable to Cu+-bridging at the protein interaction interface.4,6,7,25-28,70 This contrast indicates 
that the Cu+-bridging-induced stabilization is insignificant for Hah1 interacting with the multi-
domain construct MBD34, possibly because the apo Hah1MBD4 interactions are already ~16 
times more stable than the apo Hah1–MBD4SD (Figure 9F). An NMR characterization of Hah1’s 
interactions with a WDP multi-domain construct containing MBDs 4–6 also showed that Cu+ 
does not greatly perturb Hah1–MBD interactions.36   
 In the presence of 2 eqv Cu+, the L4MidE /EDissoc and 
L4
HighE /EDissoc area ratios both decrease 
by a factor of ~2 compared with the apo and 1 eqv Cu+ conditions (Figure 11D).  This decrease 
in stability can be attributed to a decrease in the average lifetimes of the L4MidE  and 
L4
HighE  states, 
Mid  and High , which also decrease by a factor of ~2  (Figure 11E).  Although the change in the 
area ratios between 1 and 2 eqv Cu+ is subtle, a t-test confirms that the values are different 
beyond error at the 95% confidence level.  Moreover, the accompanying decrease in Mid  and 
High  by the same factor (~2) further validates our observation.  No further change was observed 
in the EFRET distribution (Figure 11C, D) or average lifetimes (Figure 11E) with 4 eqv Cu+, 
indicating that both proteins are fully metallated at 2 eqv Cu+. 
 The observed destabilization of the Hah1–MBD4 interactions at excess Cu+ relative to 
the apo condition was not observed in the Hah1–MBD4SD interactions.70  Therefore, the 
destabilization must be associated with the multi-domain nature of MBD34 compared with the 
isolated MBD4SD. It is possible that the full metallation disrupts the concerted actions between 
the two domains of MBD34 for interacting with Hah1. 
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Figure 11. Compiled EFRET distributions (bin size = 0.03) and Gaussian fits for Cy5-Hah1 + 
Cy3-MBD34L4 in the presence of (A) 1 eqv, (B) 2 eqv, and (C) 4 eqv of Cu+ per protein pair.  
The EFRET distributions were fitted globally with those in Figure 9 by sharing the center values 
and widths of each EFRET state. The area ratio between L4LowE   and L4DissocE  was kept constant using 
the approximation that the isolated Hah1MBD3 interactions (represented by L4LowE  ) should be 
largely independent of Cu+.  (D) The area ratios of L4MidE  and 
L4
HighE  with respect to 
L4
DissocE  for 
Cy5-Hah1 + Cy3-MBD34L4 with varying equivalents of Cu+.  (E) The average dwell times of 
L4
MidE  and 
L4
HighE , Mid  and High  respectively, for Cy5-Hah1 + Cy3-MBD34L4 with varying 
equivalents of Cu+. 
 
 
 
5
10
15
 
 
  
 
 
EMid / EDissoc
EHigh / EDissoc
A
re
a 
R
at
io
D
0 1 2 3 4
0.4
0.8
1.2     
    
Eqv of Cu+ per Pair
A
ve
ra
ge
 
D
w
el
l T
im
e 
(s
)
High
MidE
0
750
1500
 
 
 
0
450
900
 
 
 
0.0 0.5 1.0
0
300
600
 
 
A
B
C
O
cc
ur
re
nc
e
EFRET
EDissoc ELow′ EMid EHigh
1 eqv Cu+
2 eqv Cu+
4 eqv Cu+
 42 
CHAPTER 4 
STRUCTURAL MODELS AND HAH1-MBD34 INTERACTION MECHANISM 
 
 We have used smFRET measurements combined with nanovesicle trapping to probe the 
weak and dynamic interactions between Hah1 and the double-domain MBD34 construct of WDP. 
By placing the FRET donor or acceptor on Hah1, MBD3, or MBD4 (Section 3.1), we have 
examined how Hah1 interacts with MBD3 and MBD4 and how MBD3 and MBD4 interact with 
each other at the single-molecule level. For all cases, we observed two major interaction 
complexes that interconvert dynamically (Section 3.2). The similarity in EFRET values across all 
labeling schemes indicates that Hah1–MBD4, Hah1–MBD3, and MBD3–MBD4 interaction 
geometries are conserved, attributable to the structural and sequence homology among Hah1, 
MBD3, and MBD4. 
 In the absence of Cu+, Hah1 interactions with MBD3 and MBD4 of MBD34 have similar 
stabilities (Section 3.3). The Hah1–MBD4 interactions are significantly more stable than the 
Hah1–MBD4SD interactions; this enhanced stability is associated with an increase in the protein 
association rate, not a decrease in the dissociation rates (Section 3.4). An overlap population 
exists between Hah1–MBD3 and Hah1–MBD4 complexes, attributable to Hah1 interacting with 
MBD3 and MBD4 simultaneously, forming 3-body interactions. These 3-body interactions were 
further supported by intramolecular-interdomain MBD3MBD4 complexes interacting with 
Hah1 (Section 3.5). 
 In the presence of Cu+ and regardless of Cu+ stoichiometry, the Hah1MBD4 interaction 
geometries appear unchanged, although the stabilities and lifetimes of the interaction complexes 
decreased under excess Cu+ (Section 3.6).  This decrease in stability may be due to a disruption 
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of concerted interactions within the double-domain MBD34, as this trend was not observed for 
Hah1–MBD4SD interactions. 
 Based on the above results, below we propose structural models for Hah1MBD34 
interactions. These models are then used to formulate a Hah1–MBD34 interaction mechanism 
that includes both 2-body and 3-body interactions between Hah1, MBD3, and MBD4. 
 
4.1. Structural Models of 2-body Protein Interaction Complexes.  
 Two major interaction geometries, EMid and EHigh, were observed for Hah1MBD4, 
Hah1MBD3, and MBD3MBD4 interactions. To better understand how Hah1 and MBD34 
interact, here we propose possible structural models of interaction complexes based on our 
smFRET results and past structural studies of these or homologous proteins. The experimental 
constraints for the structural models include:  (1) The distance r between the donor and acceptor 
labeling sites in the complexes should be consistent with the observed EFRET values of EMid and 
EHigh.  From the calibration curve measuring EFRET as a function of r (Figure S1A), for EMid = 
0.50, r ~ 5 ± 1 nm, and for EHigh = 0.75, r ~ 3 ± 1 nm.  (2) The stabilities of the interaction 
complexes should be comparable, as observed in our smFRET thermodynamic analysis (Chapter 
3, Section 3.3).  (3) The protein interaction interfaces for the complexes giving rise to EMid and 
EHigh should be spatially distinct (i.e., no significant overlap) because our data indicate 
simultaneous 3-body interactions between Hah1, MBD3, and MBD4. 
 Hah1 and all WDP/MNK MBDs share the same  protein fold and all contain the 
CXXC motif. The two -helices are on one side of the protein (i.e., the “face” side) and the four 
-strands form a -sheet on the other side (i.e., the “back” side). In our cartoon representations of 
the interaction models we denote the “face” side of the protein with a green helix and the “back” 
side with a purple arrow (Figure 12). 
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 In our previous study of Hah1MBD4SD interactions,70 we have proposed a structural 
model giving rise to the EMid state based on an interaction geometry between Hah1 and the 1st N-
terminal MBD of MNK, MNK1, observed by NMR (Figure 3).29  This interaction geometry was 
also observed between yeast homologs Atx1 and Ccc2a by NMR,55 and in Hah1 dimers by X-ray 
crystallography.25  In this geometry, Hah1 and MBD interact in a face-to-face manner: their 
CXXC motifs face each other, where a metal ion can coordinate to cysteines from both proteins, 
thus offering a facile pathway for metal transfer via ligand exchange.4,6,7,25-27 We generated these 
face-to-face structural models between Hah1, MBD4, and MBD3 by superimposing the 
structures of MBD4 and MBD357 onto the Hah1–MNK1 structure (Figure 12A). We abbreviate 
these complexes as Hff4, Hff3, and 3ff4, where H stands for Hah1, 4 (or 3) stands for MBD4 (or 
MBD3), and the “ff” subscripts designate the face-to-face interaction mode of the two 
proteins/domains. In all three models, the donor-acceptor distances, r, range from ~3.9–4.4 nm, 
giving expected EFRET ~0.540.63, within error of EMid (Table 2). 
 To further assess these face-to-face models, we examined their interaction stability using 
PISA (Protein Interfaces, Surfaces and Assemblies service at the European Bioinformatics 
Institute, http://www.ebi.ac.uk/pdbe/prot_int/pistart.html),81 in comparison with the same 
analysis on the experimentally observed face-to-face Hah1MNK1 interaction (Table 2).  All the 
face-to-face models (Hff4, Hff3, and 3ff4) have comparable stability to the Hah1MNK1 complex 
based on the buried surface area (BSA, ~ 510620 Å2), solvation free energy change (−∆Gsolv, ~ 
511 kcal/mol), and favorable interactions between residues (H-bonding and salt bridges).  
Appendix, Section S4.1 describes the residues involved in these face-to-face models. 
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Figure 12. Structural models of (A) face-to-face, (B) head-to-head, and (C) face-to-back 
interaction models and corresponding cartoon representations showing the distance between the 
donor and acceptor, r.  The models were generated by overlaying Hah1 (1FEE, red),25 MBD3 
(2ROP, yellow),57 and MBD4 (2ROP, blue)57 with the Hah1–MNK1 NMR structure (2K1R, 
grey)29 for face-to-face (A), the Atx1 dimer crystal structure (2XMT, grey)58 for head-to-head 
(B), and the Hma7 MBD dimer crystal structure (3DXS, grey)59 for the face-to-back (C). In 
overlaying, the distance between the backbone α-carbons were minimized using the iterative 
magic fit function in SwissPDB Viewer,82 followed by an energy minimization of the side-chains 
using the GROMOS 43B1 force field.83 
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Table 2. Analysis of Face-to-Face, Head-to-Head, and Face-to-Back Complexes 
Structure  BSA (Å2)a  
ΔGsolv  
(kcal/mol)b 
Favorable 
Interactions  r (nm)
c  Expected EFRETd  
Observed 
EFRET 
Hah1–
Mnk1e 539  –5.5 
6 H-bonds, 
5 Salt Bridges 4.77 0.49 ± 0.13  
EMid =  
0.50 ± 0.02 
Hff4  510  –8.0 
5 H-bonds,  
1 Salt Bridge 4.44 0.54 ± 0.13 
Hff3  579  –6.2 
6 H-bonds,  
1 Salt Bridge 4.22 0.57 ± 0.13  
3ff4  616  –11.2 1 H-Bond  3.86 0.63 ± 0.12  
Atx1 
Dimerf  235  –7.8  1 H-bond  2.66  0.80 ± 0.09  
EHigh =  
0.75 ± 0.02 
Hhh4  375  –7.8  1 H-bond  4.31  0.56 ± 0.13 
Hhh3  166  –2.6  1 Salt Bridge 4.11  0.59 ± 0.13  
3hh4  468  –10.5  2 H-Bonds  3.65  0.66 ± 0.12  
Hma7 
Dimerg  370  –2.8 
10 H-bonds, 
1 Salt Bridge 3.28 0.73 ± 0.11  
EHigh =  
0.75 ± 0.02 
Hfb4#  283  –2.9 3 H-bonds 3.91 0.62 ± 0.13  
Hbf4  240  –0.7 1 H-bond 3.01 0.75 ± 0.10  
Hfb3  179  +0.9 1 H-bond 4.20 0.58 ± 0.13  
Hbf3#  334  –2.2 2 H-bonds 2.85 0.77 ± 0.10  
3fb4#  426  –6.2 5 H-bonds 3.28 0.71 ± 0.11  
3bf4  243 –0.4 1 H-bond 3.76 0.64 ± 0.12  
aBuried surface area.  bSolvation free energy change. cDistance between Cy3 and Cy5 labeling
sites. dCalculated using the EFRET calibration curve (Figure S1A). ePDB code 2K1R. fPDB code 
2XMT. gPDB code 3DXS. #Indicates the more favorable interaction complexes based on 
interface analysis.  
 
 47 
 For the structural model of protein interactions giving rise to EHigh, there are two 
candidates from past studies on homologous proteins. One candidate is the crystal structure of a 
Atx1 dimer,58 in which the two monomers interact “head-on” symmetrically in the α-helical and 
loop region next to the CXXC motif (Figure 12B and Appendix, Section S4.2); we refer to this 
interaction geometry as head-to-head. The other is the crystal structure of an asymmetric dimer 
of the MBD of Hma7, a Cu+-transporting ATPase in Arabidopsis thaliana; this MBD is 
homologous to Hah1 and WDP/MNK MBDs.59  In this Hma7 MBD dimer, the face side of one 
monomer interacts with the back side of the other monomer (Figure 12C and Appendix, Section 
S4.3); we refer to this interaction geometry as face-to-back. 
 Using the head-to-head structure of the Atx1 dimer, we generated the corresponding 
structural models of Hah1MBD4, Hah1MBD3, and MBD3MBD4 interactions, abbreviated  
as Hhh4, Hhh3, and 3hh4, respectively (Figure 12B). The three models all have comparable 
stability to that of the Atx1 dimer (Table 2).  However, the expected EFRET is ~0.56–0.66 (Table 
2), which is smaller than the experimentally observed EHigh (~0.75). Furthermore, in all three 
cases, the interaction interface has a considerable overlap (~70%) with that of the face-to-face 
model (Appendix, Section S4.1 vs. S4.2); this overlap would forbid a coexistence of the head-to-
head and face-to-face interactions in a 3-body interaction among Hah1, MBD4, and MBD3. 
Thus, the head-to-head interaction geometry is a less likely model for the EHigh state, although we 
cannot definitively rule it out. Appendix, Section S4.2 describes the residues involved in the 
head-to-head interaction models.  
 To generate the face-to-back interaction models using the Hma7 MBD dimer structure, 
there are two possible combinations for each pair between Hah1, MBD4, and MBD3. In one 
combination, one protein presents its face side, and the other protein presents its back side. In the 
other combination the two proteins switch in position.  This leads to a total of six different face-
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to-back interaction models (three of which are presented in Figure 12C):  Hfb4 or Hbf4, Hfb3 or 
Hbf3, and 3fb4 or 3bf4.  The interaction stability analysis indicates that for each interaction pair, 
one combination is clearly more favorable than the other (Table 2). For example, the interface of 
the Hfb4 model has a larger buried surface area, more negative ∆Gsolv,, and more H-bonds than 
that of Hbf4. Similarly, Hbf3 is more favorable than Hfb3, and 3fb4 more favorable than 3bf4. The 
three more favorable combinations (Hfb4, Hbf3, and 3fb4) also have stabilities comparable to the 
experimentally observed Hma7 MBD dimer and the face-to-face models (Table 2). We thus 
chose these three as the likely face-to-back interaction models. Their expected EFRET values 
(~0.62–0.77) are also consistent with the observed EHigh (~0.75).  Furthermore, the face and 
back sides do not overlap, allowing for possible coexistence of face-to-back and face-to-face 
interactions in a 3-body interaction complex (see Section 4.3).  Appendix, Section S4.3 describes 
the residues involved in the face-to-back interactions. 
 
4.2. Molecular Dynamics Simulations of Hah1–MBD4 Interaction Models  
 To further assess the face-to-face, face-to-back, and head-to-head interaction geometries, 
we used Hah1MBD4 interactions as representatives and performed molecular dynamics 
simulations on the four possible models: Hff4, Hfb4, Hbf4, and Hhh4. All simulations were 
performed by Linghao Zhong (Pennsylvania State University, Mont Alto).  Computational details 
for the simulations are found in Appendix, Section S5.  Figure 13A presents the center-of-mass 
(COM) distance between the two proteins as a function of simulation time to assess the inter-
protein distances and relative stability/association of the Hah1–MBD4 interaction models.  The 
distance between the donor and acceptor labeling sites (r, Figure 13B) vs. simulation time is also 
presented as this distance gives rise to our EFRET observables.  The Hff4 inter-protein distance 
remains stable, ~25 Å, throughout the simulation, with an r ~ 5 nm corresponding to the EMid 
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state.  This further supports the Hff4 model as the geometry giving rise to the EMid state.  At 6 ns, 
the Hfb4 complex undergoes a slight shift in inter-protein distance, from ~25 to ~28 Å, but 
remained stable through the rest of the simulation.  Additionally, the Hfb4 complex retains an r of 
~3 nm, which is consistent with the EHigh state.  The Hbf4 complex quickly dissociates as 
indicated by the sharp increase in inter-protein distance at 1.5 ns (>40 Å), which is consistent 
with our PISA interface analysis that indicated this complex was unfavorable (Section 4.1).  For 
the Hhh4 model, its geometry is unstable, and its protein distance fluctuates in and out of 
association/dissociation before finally reaching a completely different geometry (denoted as 
“Hhh4_new”).  While the donor-acceptor distance, r ~ 3 nm, suggests this Hhh4_new geometry 
could be within the EHigh state, no experimental evidence exists for this new geometry and it 
could correspond to a local minimum within the MD simulation. Regardless, the initial Hhh4 
geometry did not remain intact and therefore is less likely a model giving rise to the Ehigh state, 
consistent with our previous assessment in Section 4.1.  
The final geometries of Hff4, Hfb4, and Hhh4_new and their interaction energies, Eint, are 
also presented in Figure 13C–D.  For Hhh4_new, Eint = 52 kcal/mol, which is much less than 
that of Hff4 (290 kcal/mol) or Hfb4 (208 kcal/mol).  In conclusion, our molecular dynamics 
simulations are in agreement with our PISA interface analysis (Section 4.1) and further support 
our proposal of the Hff4 and Hfb4 models to the EMid and EHigh observables.   
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Figure 13. (A) The inter-protein distance (between the center-of-mass, COM, of each protein) 
and donor-acceptor distance, r, are plotted vs. molecular dynamics simulation time for Hff4 
(black), Hfb4 (green), Hbf4 (magenta), and Hhh4 (violet).  The final structures (Hah1 in red and 
MBD4 in blue) and interaction energies, Eint, are shown for Hff4 (C), Hfb4 (D), and “Hhh4_new” 
(E).  The Hhh4_new is distinct from the initial Hhh4 geometry.  Eint is a rough estimation of the 
stability and does not directly correspond to the free energies of interaction (typically, ~few 
kcal/mol, as determined by PISA and previous MD simulations).32 
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4.3. Structural Models of 3-body Hah1–MBD34 Interactions.   
 Using the models of the 2-body interactions (Hff4, Hff3, 3ff4, Hfb4, Hbf3, and 3fb4, Figure 
12A,C), four different 3-body interactions are possible: Hfb4ff3, Hff4bf3, 3fbHff4, and 3fbHfb4 
(Figure 14). The first two involve Hah1 interacting with the two MBD3MBD4 intramolecular 
complexes: for example in Hfb4ff3, Hah1 interacts with MBD4 in a face-to-back geometry, while 
MBD4 and MBD3 are in a face-to-face geometry (Figure 14A). The latter two have Hah1 
sandwiched between MBD3 and MBD4. 
 To check if the linkage between MBD4 and MBD3 would forbid these 3-body 
interactions, especially the two where Hah1 is sandwiched between the MBDs, we measured the 
distance between the C-terminal of MBD3 and the N-terminal of MBD4 in all 3-body interaction 
models (Table 3); the distances range from 2.1 to 5.8 nm, significantly shorter than the average 
linker length of 7.4 ± 0.7 nm from the NMR structure of MBD34 (Figure 7). In addition, Hah1 
does not obstruct the space between the C-terminal of MBD3 and the N-terminal of MBD4 in 
these 3-body models.  Therefore, the linker region of MBD34 should be long and flexible 
enough to accommodate the proposed 3-body interactions. 
 For the two proteins located on the outer-most side of the 3-body interaction, the distance 
between the donor and acceptor labeling sites is short enough (4.4–5.7 nm) to result in an 
apparent EMid state (EFRET ~0.4–0.5) if these sites are labeled (Table 3).  For the Cy5-Hah1 + 
Cy3-MBD34L3 labeling scheme, the Hfb4ff3 (d) and Hff4bf3 (e) species would be within the L3MidE  
state.  For the Cy3Cy5-MBD34L34 experiment in the presence of unlabeled Hah1, the 3fbHff4 (i) 
and 3fbHfb4 (h) species would be observed within the L34MidE  state. 
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Table 3. Hah1–MBD34 3-Body Model Dimensions 
3-Body Model  
MBD3(C-term)–
MBD4(N-term) 
Distance (nm) a  
Outer-most r 
(nm) b  
Outer-most 
Expected EFRET  
Hfb4ff3 (d)  4.12 rH3 = 5.64 0.37 ± 0.11  
Hff4bf3 (e)  2.14 rH3 = 5.68 0.36 ± 0.11  
3fbHff4 (i)  5.81 r34 = 4.44 0.54 ± 0.13  
3fbHfb4 (h)  3.80 r34 = 4.59 0.52 ± 0.13  
aDistance between α-carbons of L93 and C124.  bDistance between donor-
acceptor labeling sites for outer-side proteins in 3-body interaction:  rH3 
represents the donor-acceptor distance between Hah1 and MBD3 in both 
Hfb4ff3 and Hff4bf3.  r34 represents the donor-acceptor distance between MBD3 
and MBD4 in both 3fbHff4 and 3fbHfb4.  cBased on EFRET calibration curve 
(Figure S1A).  
 
 
Hfb4ff3 (d)A Hff4bf3 (e)B 3fbHff4 (i)C 3fbHfb4 (h)D
Hah1 MBD4 MBD3 Hah1 MBD4
MBD3
Hah1 MBD4MBD3 Hah1 MBD4MBD3
Figure 14. Illustration of 3-body Hah1 (red), MBD3 (yellow),
MBD4 (blue) models derived from overlaying combinations of
“Face-to-Face” and “Face-to-Back” interactions.  The linker region
is hand-drawn schematically in grey. (A) Hfb4ff3 (d) and (B)
Hff4bf3 (e) involve Hah1 interacting with MBD34 intramolecular-
interdomain complexes, while (C) 3fbHff4 (i) and (D) 3fbHfb4 (h)
involve Hah1 sandwiched between MBD3 and MBD4.  The
cartoon representations are shown below each model. 
 
 53 
4.4. Kinetic mechanism of Hah1–MBD34 Interactions.  
 
 Taking into account the dissociated state, the six possible 2-body interactions, and the 
four possible 3-body interactions, we can formulate a kinetic mechanism for Hah1MBD34 
interactions (Scheme 2), where each chemical species is indexed alphabetically (a)–(k).  This 
mechanism includes the following major features that were observed experimentally: (1) 
intermolecular binding and unbinding of Hah1 with MBD4 or MBD3, each forming two 
interaction geometries, (2) intramolecular binding and unbinding between MBD4 and MBD3, 
forming two interaction geometries, (3) interconversion between interaction geometries, and (4) 
formation of 3-body interactions between Hah1, MBD4, and MBD3. 
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 The mechanism in Scheme 2 is certainly dependent on the structural models for the 
observed EMid and EHigh states.  The interaction geometries here are only models that are 
supported by data and deduced from known structures of protein complexes. Within either EMid  
or EHigh states, additional subpopulations could exist that are unresolved in our measurements.  
The dynamic linker between MBD4 and MBD3 may also play a role in the complex formation.33  
Although the details of the mechanism of Hah1–MBD34 interactions may vary, the proposed 
mechanism here intends to convey the major features of their interactions within the limit of our 
measurements. Below we use this mechanism to provide a more quantitative description of, as 
well as functional insights into, Hah1MBD34 interactions. 
 
Scheme 2. Proposed Hah1–MBD34 interaction mechanism based on the structural models 
including 2-body Hah1–MBD3, Hah1–MBD4, and MBD3–MBD4 interactions in face-to-face 
or face-to-back orientation (Hff3, Hbf3, Hff4, Hfb4, 3ff4, and 3fb4) and 3-body interactions 
(Hfb4ff3, Hff4bf3, 3fbHfb4, and 3fbHff4). 
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4.5. Relation of Chemical Species to EFRET States.  
 Depending on where Cy3 and Cy5 are labeled on Hah1 and MBD34 (Figure 8A, D, and 
G), the species in Scheme 2 have different EFRET values. Here we describe the assignment of 
these chemical species to each EFRET state considering the labeling positions within our models. 
 The Hah1–MBD34 interaction mechanism along with the expected EFRET observables for 
the Cy5-Hah1 + Cy3-MBD34L4 (Scheme 3), Cy5-Hah1 + Cy3-MBD34L3 (Scheme 4), and 
Cy3Cy5-MBD34L34 (Scheme 5) labeling schemes are presented for further clarification.  Each 
chemical species is indexed alphabetically (a)–(k), as in Scheme 2, for convenient referencing in 
the subsequent discussion.  Table 4 summarizes the assignments, along with the population 
percentages of each species calculated using the relative Gaussian areas and thermodynamic 
decomposition (see Section 4.6). The dissociated state, EDissoc (green), is the same regardless of 
the labeling scheme, as it always contains 34ext (a), 3ff4 (b), and 3fb4 (c).   
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Scheme 3. Expected EFRET observables for the Cy5-Hah1 + Cy3-MBD34L4 labeling scheme. The 
dashed boxes outline the species contained in each EFRET state. 
 
 For Cy5-Hah1 + Cy3-MBD34L4 (Scheme 3), all Hah1–MBD4 face-to-face interaction 
geometries (Hff4bf3 (e), Hff4 (g), and 3fbHff4 (i)) occur within L4MidE  (blue), while all Hah1–MBD4 
face-to-back interaction geometries (Hfb4ff3 (d), Hfb4 (f), and 3fbHfb4 (h)) occur within L4HighE  
(red).  When Hah1 is interacting with the unlabeled MBD3 independently (Hbf3 (j) and Hff3 (k)), 
this is observed within the L4LowE   state (magenta). 
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Scheme 4. Expected EFRET observables for the Cy5-Hah1 + Cy3-MBD34L3 labeling scheme. The 
dashed boxes outline the species contained in each EFRET state. 
 
 For Cy5-Hah1 + Cy3-MBD34L3 (Scheme 4), the Hah1–MBD3 face-to-face interaction 
geometry, Hff3 (k), occurs within L3MidE  (blue), while all Hah1–MBD3 face-to-back geometries 
(3fbHfb4 (h), 3fbHff4 (i), and Hbf3 (j)) occur within L3HighE  (red).  When Hah1 is interacting with the 
unlabeled MBD4 independently (Hfb4 (f) and Hff4 (g)), this is observed within the L3LowE   state 
(magenta).  As described previously in Section 4.3, the Hfb4ff3 (d) and Hff4bf3 (e) species should 
occur within the L3MidE  state (blue) due to the close proximity of Hah1 and MBD3. 
 58 
 
Scheme 5. Expected EFRET observables for the Cy3Cy5-MBD34L34 labeling scheme in the 
presence of one unlabeled Hah1 molecule. The dashed boxes outline the species contained in 
each EFRET state. 
 
 For Cy3Cy5-MBD34L34 in the presence of one unlabeled Hah1 molecule (Scheme 5), all 
MBD34ext conformations (34ext (a), Hfb4 (f), Hff4 (g), Hbf3 (j), and Hff3 (k)) occur within L34LowE   
(magenta).  The face-to-face MBD3–MBD4 interactions (3ff4 (b) and Hfb4ff3 (d)) give rise to the 
L34
MidE  state (blue), while the face-to-back MBD3–MBD4 interactions (3fb4 (c) and Hff4bf3 (e)) 
give rise to the L34HighE  state (red).  The species where Hah1 is sandwiched in between MBD3 and 
MBD4 (3fbHfb4 (h) and 3fbHff4 (i)) will also give rise to the L34MidE  state (blue) due to the close 
proximity of MBD3 and MBD4, as indicated in Section 4.3. 
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Table 4. EFRET Assignments of Chemical Species for Each Labeling Scheme and 
Their Population Percentagesa 
Chemical 
Species 
Cy5-Hah1 + 
Cy3-MBD34L4 
Cy5-Hah1 + 
Cy3-MBD34L3 
Cy3Cy5-
MBD34L34 P (%)
a 
34ext (a) EDissoc EDissoc ELow′ 1.1 ± 0.2 
3ff4 (b) EDissoc EDissoc EMid 0.6 ± 0.1 
3fb4 (c) EDissoc EDissoc EHigh 0.6 ± 0.1 
Hff4 (g) EMid ELow′ ELow′ 25 ± 6 
Hfb4 (f) EHigh ELow′ ELow′ 20 ± 5 
Hff3 (k) ELow′ EMid ELow′ 18 ± 8 
Hbf3 (j) ELow′ EHigh ELow′ 17 ± 8 
Hfb4ff3 (d) EHigh EMid EMid 4 ± 2 
Hff4bf3 (e) EMid EMid EHigh 4 ± 2 
3fbHfb4 (h) EHigh EHigh EMid 4 ± 2 
3fbHff4 (i) EMid EHigh EMid 4 ± 2 
aPopulation percentages of chemical species obtained as described in Section 4.6.
 
 
4.6. Thermodynamic Decomposition and Quantification of Hah1–MBD34 Interactions.  
 With the EFRET assignments of the chemical species (a)–(k) for each labeling scheme 
(Scheme 3, Scheme 4, Scheme 5, and Table 4) and the relative stabilities of the EFRET states from 
the EFRET distributions (Figure 9B-D), we can now decompose the population percentages of 
these species (i.e., the relative occurrence of each species at any time point among many 
interacting pairs) and examine their thermodynamic properties.  
 From the Gaussian-resolved EFRET distributions (Figure 9B-D), the area percentage () of 
each EFRET state represents the sum of the population percentages (P) of all the chemical species 
contributing to that EFRET state. For example, in the Cy5-Hah1 + Cy3MBD34L4 labeling scheme 
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(Scheme 3), the area percentage ( L4Dissoc ) of the L4DissocE  state equals the sum of population 
percentages of 34ext (a), 3ff4 (b), and 3fb4 (c) that constitute the dissociated state: 
L4
Dissoc a b c DissocP P P P       (3.1) 
Here, Px denotes the population percentage of chemical species x.  For the area percentages of 
the L4LowE  , L4MidE , and L4HighE  states,  
L4
Low k jP P     (3.2) 
L4
Mid g e i g 2 SP P P P P       (3.3)  
 L4High f d h f 2 SP P P P P       (3.4)  
and 
L4 L4 L4 L4
Dissoc Low Mid High 1       . 
 Similarly, for the Cy5-Hah1 + Cy3-MBD34L3 labeling scheme (Scheme 4): 
L3
Dissoc a b c DissocP P P P      (4.1) 
L3
Low g fP P     (4.2) 
L3
Mid k d e g 2 SP P P P P       (4.3) 
L3
High j h i j 2 SP P P P P       (4.4) 
and L3 L3 L3 L3Dissoc Low Mid High 1       . Note, L3 L4Dissoc Dissoc  , as the dissociated state is the same for 
these two labeling schemes; this relationship was also used in constraining the global Gaussian-
resolution of the EFRET distributions in Figure 9B and C. 
 The chemical species 34ext (a), 3ff4 (b), and 3fb4 (c) are resolved in the labeling scheme 
Cy3Cy5-MBD34L34 and correspond to the L34LowE  , L34MidE , and L34HighE  states, respectively (Figure 
9D).  The area percentages in Figure 9D are related to the population percentages by: 
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L34
Low a DissocP P    (5.1) 
L34
Mid b DissocP P   (5.2) 
L34
High c DissocP P   (5.3) 
where Dissoc a b cP P P P    as in equations 3.1 and 4.1. 
 Unfortunately the above equations are underdetermined for solving for the population 
percentage of every species in Scheme 2. We thus approximated that all 3-body interaction 
species have similar stabilities; i.e., their population percentages are approximately the same: 
d e h i SP P P P P    . This should be a valid approximation because the face-to-face and face-to-
back interactions (and thus any combination thereof) have comparable stabilities (Chapter 3, 
Section 3.3). This approximation leads to the simplification of equations 3.3, 3.4, 4.3, and 4.4 
and allows for solving for the population percentages of the chemical species (Table 4).  Also, 
because of this approximation, PS effectively represents the average population percentage of all 
3-body interaction species. 
 Using the population percentage of each species and the effective concentration (Ceff) of 
each protein inside the nanovesicle (~6 ± 5 M),70 we can compute the equilibrium constants of 
the kinetic processes in Scheme 2.  These equilibrium constants can be classified into four 
categories (Table 5):  (1) Dissociation constants, KD, of Hah1 binding to either MBD4 or MBD3 
(e.g., fDK , 
g
DK , 
j
DK , 
k
DK , 
d
DK , and 
e
DK ), (2) stability constants, KA, of intramolecular-
interdomain interactions (e.g., bAK  and 
c
AK ), (3) interconversion equilibrium constants, Kint, 
between different interaction geometries (e.g., H4intK , 
H3
intK , and 
34
intK ), and (4) stability constants, 
KA, of the 3-body interactions relative to the 2-body interactions (e.g., S/fAK , 
S/g
AK , and 
S/j
AK ).  
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 The dissociation constants (KD) range from 101 to 100 μM, in agreement with the SPR 
studies,52,53 and an order of magnitude smaller than the Hah1MBD4SD interactions.  This likely 
comes from an increased rate of association (see Chapter 3, Section 3.4), perhaps because of 
additional electrostatic/orientational steering present in the double-domain MBD34 for 
interacting with Hah1.84  The interconversion equilibrium constants (Kint) are around 1, 
consistent with the two Hah1MBD interaction geometries having comparable stabilities. From 
the stability constants (KA ~ 0.2), the 3-body interactions are less stable than the 2-body 
interactions, perhaps due to entropy loss in forming 3-body interactions. 
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Table 5. Equilibrium Constants for the Hah1–MBD34 Interaction 
Mechanism in Scheme 2a 
Dissociation 
Constant and 
Definitionb 
Value (μM) 
Equilibrium 
Constant and 
Definition 
Value  
 f a fD effP P CK   0.34 ± 0.28 H4int g fK P P 1.3 ± 0.4 
 g a gD effP P CK   0.27 ± 0.22 H3int k jK P P  1.1 ± 0.7 
  
34
int b cK P P 1.0 ± 0.3 
 j a jD effP P CK   0.41 ± 0.37 bA b aK P P  0.56 ± 0.15 
 k a kD effP P CK   0.37 ± 0.33 cA c aK P P  0.56 ± 0.15 
  
S/f
A S fK P P 0.21 ± 0.13 
 d b dD effP P CK   0.92 ± 0.89 S/gA S gK P P 0.16 ± 0.10 
 e c eD effP P CK   0.92 ± 0.89 S/jA S jK P P  0.25 ± 0.18 
aPx represents the relative population of chemical species x as 
annotated in Scheme 2. bCeff is the effective protein concentration 
inside the nanovesicle, 6 ± 5 μM, calculated using the vesicle inner-
diameter, 80 ± 20 nm.70 
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4.7. Functional Implications of Hah1–MBD34 Interactions.  
 Inside cells Hah1 delivers Cu+ to WDP (or MNK), which translocates Cu+ across the 
Golgi membrane for either incorporation to downstream copper proteins or efflux. Many features 
of the interactions between Hah1 and the double-domain WDP construct MBD34 are 
advantageous for fulfilling this function. These advantages are better illustrated by an analogy to 
the modern cargo transportation industry. In this analogy, Hah1 behaves like a delivery truck 
with Cu+ as its cargo.  The N-terminal region of WDP, with multiple MBDs, behaves like a 
warehouse distribution center, where the MBDs are the loading docks. The distribution center 
must operate with both efficiency and versatility to receive, re-route, and export shipments from 
many trucks.   
 The operation versatility of the WDP distribution center is accomplished by providing 
multiple MBD docking sites for the Hah1 truck to deliver its cargo. The truck can park frontward 
or backward at the dock (i.e., with two Hah1MBD interaction geometries). Even better, the 
truck can interconvert between its docking geometries dynamically, thus allowing either of the 
two interfaces to be exposed for interaction with an additional MBD. The 3-body interactions 
where Hah1 is sandwiched between MBDs allow for the re-routing of the delivery truck, i.e., a 
Hah1 molecule can be handed over directly from one MBD to another.  This re-routing of Hah1 
would especially be useful when the initially targeted MBD is already loaded with Cu+.  
Consistent with this scenario, a decrease in complex stability and lifetime was observed when 
Hah1 and MBD34 are fully metallated (Chapter 3, Section 3.6), assisting the departure of Hah1.  
 WDP’s intramolecular MBDMBD interactions provide a way for internal redistribution 
of the Cu+ cargo, either to vacate space for next Hah1 delivery or to traffic Cu+ downstream. This 
redistribution also occurs in a versatile manner, as multiple binding geometries were observed 
between MBD3 and MBD4. This internal cargo redistribution among MBDs can be directly 
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coupled to the cargo delivery or export through Hah1 interactions with the intramolecular 
MBDMBD complexes. 
 All of these processes occur on similar timescales (~1 s), including the protein 
associations at the effective M concentration inside nanovesicles. (Note the intracellular 
concentration of the yeast Hah1 homologue Atx1 is also about M.85) Their similarity in 
timescale suggests that all these processes should occur comparably inside cells for function. 
 Our proposed Hah1–MBD34 interaction mechanism may also help understand the 
regulatory function of the MBDs, where Hah1–MBD or MBD–MBD interactions modulate the 
ATPase activity associated with Cu+-translocation13,18,40,44,45 or the kinase-mediated 
phosphorylation associated with the relocalization of WDP/MNK for Cu+-efflux.13,39,46-50  It was 
proposed that large-scale conformational changes within the N-terminal tail of WDP/MNK act as 
the regulatory switch,30,33,35,41-43 which disrupts MBD interactions with the catalytic core 
affecting Cu+-translocation or exposes/hides phosphorylation sites in the linker regions. The 3-
body interactions where Hah1 is sandwiched between MBDs could induce large-scale 
conformational changes in the cytoplasmic tail of WDP, and hence may play a role in this 
regulatory switching mechanism.   
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CHAPTER 5 
SUMMARY AND FUTURE DIRECTIONS 
 
5.1. What We Learned 
 We have systematically characterized the interaction dynamics of Hah1 with a multi-
domain construct of WDP, MBD34 using smFRET.  Two conserved, dynamically 
interconverting, protein interaction geometries were observed between Hah1–MBD3, Hah1–
MBD4, and MBD3–MBD4. Hah1 interacts with MBD3 and MBD4 with a similar stability 
within MBD34, and may even interact with both MBDs simultaneously by forming 3-body 
interactions with a relative occurrence of ~16%.  Compared with an isolated MBD4 (MBD4SD), 
Hah1MBD4 interactions within the multi-domain construct are more stable by an order of 
magnitude, suggesting that concerted interactions facilitate complex formation. The kinetics and 
thermodynamics of the intramolecular-interdomain MBD3–MBD4 interactions were quantified. 
We further studied the Cu+-dependence of Hah1–MBD4 interactions and found they become 
destabilized at excess Cu+ concentrations.   
 We further proposed models for Hah1MBD34 interactions, including 2-body and 3-
body interactions, and formulated a kinetic mechanism that includes all our experimentally 
observed interaction processes. We were able to quantify the equilibria between different 
chemical species in our proposed interaction mechanism by using the relative area percentages 
obtained from the Gaussian-resolved EFRET distributions.  The Hah1-MBD34 interaction 
dynamics suggest an efficient and versatile means for WDP (or MNK) to receive, re-route, and 
export Cu+ that is delivered by Hah1, analogous to a modern-day warehouse distribution center.  
The simultaneous 3-body interactions between Hah1, MBD3, and MBD4 may also induce large-
scale conformational changes in the N-terminal tail which could serve as a regulatory switch for 
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WDP/MNK function. 
 
5.2. Future Directions 
5.2.1. Further Interrogation of Hah1–MBD and MBD–MBD Interactions.   
 Due to the complexity of the Hah1–MBD and MBD–MBD interaction dynamics within 
the full WDP system, there are many variations of future smFRET experiments that could further 
interrogate this multi-bodied interaction network.  Ideally, these experiments should build on our 
previous and current studies while providing further functional insight into the mechanisms of 
Cu+ trafficking in the cell. 
 To further interrogate how intramolecular-interdomain MBD3–MBD4 interactions are 
coupled to intermolecular interactions with Hah1, we can immobilize the Cy3Cy5-MBD34L34 
construct, modified with an Avitag (a sequence of amino acids that binds to biotin) at the N-
terminus, on a biotinylated PEG-coated surface.  Unlabeled Hah1 can then be flowed at varying 
concentrations to monitor the perturbation in the MBD3–MBD4 dynamics via smFRET (Figure 
15A).  We could also probe all three interactions simultaneously using 3-color smFRET.86-88  
This would involve cotrapping Cy3-Hah1 and MBD34L34 labeled with two acceptors, Cy5 and 
Cy5.5 (or Cy7), within the nanovesicle (Figure 15B).  Such an experiment, although technically 
challenging due to substantial overlap in the fluorophore emission spectra, would directly 
confirm the presence of our proposed 3-body interactions between Hah1, MBD3, and MBD4. 
 We could also investigate other MBD–MBD interaction dynamics within the WDP 
system using smFRET.  Because we have already probed intramolecular interactions between 
MBD4 and the adjacent MBD3, it would be interesting to look at MBD4’s interactions with a 
more distant MBD; e.g., MBD2 or MBD1.  We already have protein constructs containing 
MBDs 1–4 and MBDs 1–6 which could be easily modified to introduce the necessary labeling 
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cysteines (Figure 15C–E).  A systematic comparison of MBD4 interactions with MBD3, MBD2, 
and MBD1 would answer whether the proximity (in primary sequence) between two MBD’s 
affects their ability to interact with one another.  Combining the information from these various 
smFRET experiments may also yield information on the overall tertiary structure of the N-
terminal tail, and how this might change in the presence of Cu+ or Hah1.  This would give direct 
evidence for the proposed large-scale conformational changes within the N-terminal tail of 
WDP/MNK which could serve as a regulatory switch for cellular relocalization or Cu+ 
translocation. 30,33,35,41-43  Various combinations of the previously mentioned 3-color smFRET 
labeling scheme could also be implemented to study the interaction of Hah1 with these larger 
multi-MBD systems. 
 Ultimately, to test whether Hah1 interacting with each MBD in multiple geometries 
and/or forming 3-body interactions is directly related to WDP/MNK function (i.e., Cu+ 
translocation or relocalization for Cu+ efflux), we would need to study the system in vivo.  
Multiple Hah1–MBD interaction geometries and 3-body interactions would be eliminated or 
disrupted by destabilizing the face-to-back interactions via mutagenesis.  For example, S124 of 
MBD4, located on the back side, could be mutated to alanine to disrupt hydrogen bonding in the 
Hfb4 interaction (Figure S10), while not effecting the Hff4 interaction.  Immunofluorescence 
microscopy can then be used to determine whether WDP retains its ability to relocalize for Cu+ 
export compared to the wild-type.39  Cellular vitality under conditions of Cu+ stress could also be 
determined by yeast complimentation assays.37,38  Additionally, the catalytic phosphorylation of 
WDP could be monitored readily using standard biochemical procedures.30,51 
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Figure 15. (A) Cy3Cy5-MBD34L34 immobilized on a PEG-coated slide using Avitag-biotin 
interactions.  Unlabeled Hah1 can be flowed at various concentrations to systematically examine 
the perturbation in MBD3–MBD4 interactions. (B) Three-color smFRET labeling scheme used 
to simultaneously probe Hah1–MBD4, Hah1–MBD3, and MBD3–MBD4 interactions. Labeling 
schemes to probe MBD4 interactions with (C) MBD3, (D) MBD2, and (E) MBD1 within a WDP 
construct containing MBDs 1–4. 
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5.2.2. Beyond Cu+:  Exploring Vitamin B12 Trafficking.   
 Besides Cu+, nature must also deliver many other potentially toxic, yet essential, 
cofactors to their cellular destinations.89  For example, the chaperone adenosyltransferase (ATR) 
binds and delivers adenosylcobalamin (AdoCbl), a Vitamin B12 derivative, to methylmalonyl-
CoA mutase (MCM).90,91  In addition to AdoCbl, other cobalamin derivatives exist depending on 
the upper-axial ligand coordinated to cobalt (Figure 16A); these include cyanocobalamin 
(CNCbl), hydroxylcobalamin (HOCbl), and methylcobalamin (MeCbl).92  Only AdoCbl and 
MeCbl are the biologically active forms of the cofactor.  For instance, MCM utilizes the labile 
organometallic bond in AdoCbl to isomerize methylmalonyl-CoA to succinyl-CoA, for use in the 
citric acid cycle.92 
 In collaboration with Prof. Ruma Banerjee and Michael Lofgren at the University of 
Michigan, we seek to first quantify the binding/unbinding dynamics of various cobalamin 
cofactors with ATR and, ultimately, understand how ATR’s interactions with MCM are coupled 
to cofactor transfer at the single-molecule level.  Because the various cobalamin derivatives 
exhibit visible absorption bands around ~460 nm, we can monitor their binding/unbinding 
kinetics to ATR in real time using single-molecule fluorescence quenching (smFQ).   
 ATR is a homotrimer, with each monomer consisting of a five-helix bundle, and three 
cobalamin binding sites located in between each monomer (Figure 16B).93-95  For our smFQ 
experiments, we took advantage of ATR’s trimeric nature.  While the introduction of a labeling 
cysteine for maleimide conjugation produces three labeling sites, one or two of these sites can be 
conjugated to a maleimide-PEG-biotin linker for immobilization, and another can be labeled 
with the maleimide fluorescent reporter (Figure 16C).  Because ATR contains three binding sites 
(with different distances from the dye) and can potentially bind two or even three substrates 
simultaneously, we expect to see multiple smFQ states. 
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Figure 16. (A) Structure of cobalamin (Cbl).  The upper axial ligand, R, can be an adenosyl 
(Ado), methyl (Me), hydroxo (OH), or cyano (CN) group. (B) Top and side views of the M. 
extorquens ATR homology model, based on the structure of M. tuberculosis ATR (PDB code 
2G2D).93  The homology model was overlayed with the L. reuteri ATR structure (PDB code 
3CI1)94 to model the AdoCbl binding sites.  The positions of the potential labeling sites, T71C, 
S99C, T120C, and S169C, are shown in green. (C) smFQ experimental set-up.  One labeling site 
is conjugated via maleimide chemistry to Alexa555, while the other two sites are conjugated to a 
PEG linker containing a biotin group.  The labeled ATR is immobilized on a PEG- or BSA-
coated quartz slide, and single Alexa555 fluorophores are excited using 532-nm TIRF.  Flowing 
various concentrations of Cbl results in dynamic binding/unbinding events, reported by smFQ.  
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 To determine the appropriate labeling sites (i.e., residues to be mutated to cysteine for 
maleimide conjugation to the dye or PEG-biotin), we considered a variety of factors:  (1) the 
residue was not conserved throughout various ATR homologues, (2) the residue was not 
involved in stabilizing secondary or tertiary structure, (3) the residue was similar to cysteine, (4) 
the residue was solvent accessible for maleimide labeling, and (5) the residue was not located too 
close to the cobalamin binding site (which we also assume constitutes the ATR–MCM interface).  
We also mutated two of the native cysteines to serines (C64S and C154S) to avoid potential 
additional labeling at these sites (site-directed mutagenesis was performed by Michael Lofgren).  
After these considerations, we chose four potential labeling sites:  T71C, T120C, S99C, and 
S169C (Figure 16B).  While all constructs retained their ability to bind and release AdoCbl 
(activity assay performed by Michael Lofgren), the T120C and S169C mutants were susceptible 
to aggregation at room temperature.  We therefore chose the T71C and S99C ATR constructs for 
our smFQ experiments. 
 After labeling the ATR constructs with Alexa555 and PEG-biotin, we performed smFQ 
experiments (Figure 16C) with various concentrations of AdoCbl, MeCbl, HOCbl, and CNCbl.  
Figure 17A illustrates a typical smFQ trace for the ATR T71C construct in the presence of 
AdoCbl.  Highly dynamic binding and unbinding events are observed with multiple smFQ states 
that are clearly distinguishable from dye blinking (such blinking events would result in intensity 
values similar to the photobleached state, ~0).  To ensure these additional states were not due to 
collision-induced quenching of the dye by the substrate, control experiments performed by Tai-
Yen Chen showed that these intensity fluctuations do not occur upon addition of AdoCbl to 
Alexa555-labeled DNA at the single-molecule level.  The highest intensity state represents the 
apo protein, while the lower intensity states represent quenching due to cobalamin binding to one 
or more of the three sites.  The normalized intensity distributions compiled for many ATR 
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molecules (Figure 17B) show the population of the lower intensity states increases with 
increasing cobalamin concentration, as expected.  These distributions also indicate the presence 
of multiple smFQ states, which can be attributed to the presence of multiple binding sites with 
different distances from the dye reporter and various cofactor binding stoichiometries (single, 
double, and triple-bound species). 
 We are currently deconvoluting the number of smFQ states present for each condition, 
possibly by using 2-dimensional smFQ state analysis (similar to that used in our smFRET study) 
or perhaps hidden Markov modeling.96,97  Once the number of states is determined, we can 
determine the thermodynamics and kinetics of cobalamin binding/unbinding through Gaussian-
deconvolution of the normalized intensity distributions and waiting time analysis of the smFQ 
states, respectively.  It is likely that smFQ information from both labeling sites (T71C and S99C) 
will be utilized as these two perspectives will yield different, yet complimentary, observables.  
These experiments will produce quantitative kinetic information on substrate specificity, which 
is important for understanding the mechanism by which ATR binds and delivers cobalamin.  We 
also intend to explore the ATR–MCM interaction dynamics, perhaps via smFRET with 
nanovesicle trapping, and explore how these are coupled to cobalamin binding/unbinding and 
transfer.  Overall, this study broadens our scope to interrogating the trafficking of other metal-
containing cofactors, where the presence of cofactor can be directly probed, thus offering a 
unique contribution to the field of bioinorganic chemistry. 
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Figure 17.  (A) smFQ trajectory of the ATR T71C construct labeled with Alexa555 in presence 
of 5 μM AdoCbl.  The light grey represents the raw intensity corrected by the TIRF laser profile 
and the black represents the data subjected to nonlinear forwards-backwards filtering (using the 
same parameters described in Chapter 2, Section 2.9).  (B) Compiled normalized intensity 
histograms for hundreds of ATR molecules showing an increase in the population of quenched 
states with increasing AdoCbl concentration.  
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APPENDIX  
 
S1. Calibration of EFRET vs. Donor-Acceptor Distance 
 An empirical EFRET vs. distance calibration curve (Figure S1A) was prepared by Debashis 
Panda by compiling smFRET data from various Holliday Junction (HJ) constructs labeled with 
Cy3 and Cy5. The EFRET values are taken as IA/(IA + ID), as described in the Chapter 2, Section 
2.9. The distances are the anchor-to-anchor distances of the FRET donor-acceptor pair Cy3Cy5. 
These HJs are four-way junctions of DNA. In the presence of salt and at room temperature, they 
form two dynamically interconverting X-shaped conformations, each like two DNA helices 
stacked on top of each other.98-100 Using structural models of these HJ conformations, the 
distances between Cy3 and Cy5 labeling sites (i.e., dye anchoring points) can be measured 
readily. The corresponding EFRET values were obtained from smFRET measurements, as we 
reported previously.76,101 
 In the calibration curve, data were included from the following HJs: HJ1 and HJ1a 
(described in Sarkar et al),76 HJC2 and HJC2a (described in Andoy et al),101 HJC3 (Figure S1B), 
HJC4 (Figure S1C), and HJC4a (Figure S1D).  For the previously unreported HJ constructs 
(HJC3, HJC4, and HJC4a), the Cy3 and Cy5 labeling positions are shown along with the names 
of each strand, “a, b, c, and d,” and the names of each arm, “M, N, P, and Q” (Figure S1B-D).  
The BiotinTEG moiety at the 5′ end of strand c was used for biotin-avidin immobilization.  
Because the HJ is in dynamic equilibrium between two conformational states, constructs with 
arms M and N/Q labeled give rise to a low EFRET state of ~0.2 and a high EFRET state of ~0.7 
(see cartoon representations of dynamic equilibrium in Figure S1B-C).  The HJC4a construct, 
however, gives rise to just one apparent EFRET state ~0.4, because Cy3 and Cy5 are within arms’ 
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M and P, which do not move significantly with respect to one another during the HJC4a’s 
structural dynamics. 
 To obtain the corresponding distances between labeling sites (i.e., anchor-to-anchor 
distances), r, for each EFRET state, a HJ model was generated by overlaying and extending B-
form DNA onto the four arms of the crystal structure of a HJ junction (PDB code 1DCW).76,98  
The distance measurement was made between two phosphate backbone atoms corresponding to 
the anchoring position of the dyes.  Within each conformation, the dye-labeled strands can be 
positioned in two possible, but slightly different ways.  In all constructs except HJC4a, this 
results in two similar donor-acceptor distances for each EFRET state:  r12 and r34 for the high EFRET 
and r12′ and r34′ for the low EFRET (Figure S1B-C).  In HJC4a, this results in four similar donor-
acceptor distances:  r12, r34, r12′, and r34′ (Figure S1D).  The distance we used for each EFRET 
state, r, was therefore taken as an average of these possibilities. 
 The data were fitted empirically using       16FRET 01E r r     , with  = 5.3 ± 0.6 
nm and β = 1.9 ± 0.1, and r0 (the Cy3-Cy5 Förster radius) fixed at the previously reported value 
of 5.4 nm.102  Here  and  are correction parameters:  corrects for the additional distance due 
to the dye linker length (since we only measured the distance between the dye anchoring points 
for r) and β corrects for deviation in r0 due to the relative orientation and linker flexibility of the 
dyes.103 Note the EFRET value used here is a simple experimental approximation (= IA/(ID+IA)), 
and it is not corrected by the relative fluorescence detection efficiencies and quantum yields of 
the donor and acceptor.102,103 Therefore, the numerical values and  and  should not be 
interpreted literally, but should be treated as empirical fitting parameters to generate a best fit to 
the data, despite their physical connection. This empirical calibration curve provides a direct 
correlation between an experimental observable and a distance quantity that can be 
independently determined using structural modeling. The fitted curve and the HJ smFRET data 
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demonstrate that the apparent EFRET varies with distance over a range relevant to our measured 
EFRET values (~0.27–0.75). 
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Figure S1. (A) Empirical EFRET calibration curve based on smFRET data for 
various Holliday junction (HJ) constructs.  The labeling schemes, dynamic 
equilibrium, and an illustration of determining r are shown for HJC3 (B), HJC4 
(C), and HJC4a (D). 
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S2. Dwell Time Distributions of EFRET States 
 The dwell times of the ELow, EMid, and EHigh states, τLow, τMid, and τHigh, respectively, can 
be compiled from many interacting pairs to examine their statistical distributions (Figure S2).  
The distributions follow an apparent single-exponential decay, f(τ) = Nexp(-τ/ ) which can be 
used to obtain the average lifetime of the EFRET state,  .  Fast transitions consisting of 1–2 image 
frames (100–200 ms) were excluded from these distributions as these dwell times and 
corresponding EFRET values are unreliable due to our experimental resolution.  The distributions 
in Figure S2 were obtained from analyzing the raw trajectories (not subjected to nonlinear 
filtering described in Chapter 2, Section 2.9).  Dwell time analysis performed after nonlinear 
filtering resulted in identical average lifetimes. 
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Figure S2.  Dwell time distributions for Cy5-Hah1 + Cy3-MBD34L4 in the presence of (A) 1 eqv 
Cu+, (B) 2 eqv Cu+, (C) 4 eqv Cu+, (D) Cy5-Hah1 + Cy3-MBD34L3, (E) Cy3Cy5-MBD34L34, 
and (F) Cy3Cy5-MBD34L34 in the presence of excess unlabeled Hah1.  The average lifetimes 
obtained from the single-exponential fit, Low , Mid , and High , are given for each distribution. 
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S3. Two-Dimensional EFRET Histogram Analysis  
 The 2-D EFRET analysis of Cy5-Hah1 + Cy3-MBD34L4, in the presence of varying 
stoichiometric equivalents of Cu+ (Figure S3A), resolves three apparent EFRET states:  L4LowE , 
L4
MidE , and 
L4
HighE .  All EFRET values are consistent with those observed in the apo condition 
(Chapter 3, Section 3.2, Figure 8C) suggesting that the Hah1–MBD4 interaction geometries 
remain largely unchanged in the presence of Cu+.  In addition, three EFRET values, L34LowE , 
L34
MidE , 
and L34HighE  were also observed for Cy3Cy5-MBD34L34 in the presence of excess Hah1 (Figure 
S3B).  The EFRET values are similar to those observed in the absence of Hah1 (Chapter 3, Section 
3.2, Figure 8I), indicating the two intramolecular MBD3–MBD4 interaction geometries are 
conserved in the presence of Hah1.  
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Figure S3. (A) Two-dimensional histogram of the average lower vs. higher EFRET 
state for Cy5-Hah1 + Cy3-MBD34L4 with varying equivalents of Cu+.  For each 
condition, three EFRET states are observed.  For 1 eqv Cu+ (249 pairs), L4LowE  = 0.25 
± 0.01, L4MidE  = 0.49 ± 0.01, and 
L4
HighE  = 0.74 ± 0.01.  For 2 eqv Cu
+ (220 pairs), 
L4
LowE  = 0.26 ± 0.01, 
L4
MidE  = 0.49 ± 0.01, and 
L4
HighE  = 0.73 ± 0.01.  For 4 eqv Cu
+ 
(183 pairs), L4LowE  = 0.25 ± 0.01, 
L4
MidE  = 0.49 ± 0.01, and 
L4
HighE  = 0.76 ± 0.01.  (B) 
The two-dimensional EFRET histogram for Cy3Cy5-MBD34L34 (187 molecules) in 
the presence of excess unlabeled Hah1 also shows three EFRET states: L34LowE  = 0.24 
± 0.01, L34MidE  = 0.51 ± 0.01, and 
L34
HighE  = 0.75 ± 0.01. 
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S4. Detailed Description of Protein–Protein Interaction Interfaces 
 Below we present the details about the interaction interfaces for the face-to-face (Section 
S4.1), head-to-head (Section S4.2), and face-to-back (Section S4.3) models. The interface 
analyses were done using PISA.81 
 
 S4.1. Face-to-Face Interaction Models. The face-to-face interaction interfaces are 
illustrated and described for the Hff4 (Figure S4), Hff3 (Figure S5), 3ff4 (Figure S6) models.  The 
interface residues are mainly located within the two α-helices and loop regions next to the CXXC 
Cu+-binding motif.  The face-to-face interaction models are also summarized in Chapter 4, 
Section 4.1 and Table 2. 
Favorable Interactions
Hah1 MBD4
Hydrogen Bonds
CYS 12 [ SG ] CYS 136 [ O ]
CYS 12 [ SG ] CYS 139 [ SG ]
CYS 15 [ H ] CYS 139 [ SG ]
ARG 21 [ NH2] ALA 132 [ O ]
CYS 12 [ SG ] CYS 136 [ H ]
THR 11 [ O ] SER 138 [ OG ]
Salt Bridges
LYS 25 [ NZ ] ASP 185 [ OD1]
Hah1 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
THR 11 24.83 -0.05
CYS 12 68.99 2.32
GLY 13 23.07 0.14
GLY 14 43.78 0.48
CYS 15 36.71 1.05
GLU 17 6.34 -0.02
ALA 18 38.08 0.54
ARG 21 84.83 -0.82
VAL 22 19.39 0.31
LYS 25 46.62 -0.98
LYS 57 46.78 0.19
THR 58 26.90 0.09
GLY 59 46.72 0.15
LYS 60 8.21 -0.13
MBD4 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ALA 132 15.79 -0.15
GLY 133 3.76 0.04
THR 135 39.15 0.54
CYS 136 20.90 0.70
SER 138  50.73 0.40
CYS 139 26.94 1.03
SER 142 28.98 -0.01
MET 146 39.00 1.11
GLU 184 19.25 -0.12
ASP 185 59.03 -0.40
MET 186 64.67 0.24
GLY 187 54.31 0.29
PHE 188 60.26 0.81
GLU 189 16.45 0.26
Hah1 MBD4Hff4
~90° ~90°
A
B C D
 
Figure S4. (A) Illustration of interface residues for Hff4.  Hah1’s interface residues are shown in 
green while MBD4’s interface residues are in orange.  In addition, each protein is rotated ~90° 
to illustrate the interface residues more clearly.  (B) Hah1 interface residues with corresponding 
buried surface area, BSA, and solvation free energy change, ΔGsolv.  (C) Favorable interactions – 
hydrogen bonds and salt bridges.  (D) MBD4 interface residues and corresponding BSA and 
ΔGsolv. 
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Favorable Interactions
Hah1 MBD3
Hydrogen Bonds
SER 20 [ OG ] GLY 87 [ O ]
ARG 21 [ H ] PRO 86 [ O ]
ARG 21 [ H ] GLY 87 [ O ]
ARG 21 [ NH2] ASP 30 [ OD2]
GLY 13 [ O ] ASN 88 [ ND2]
GLY 14 [ O ] ASN 88 [ ND2]
GLY 59 [ O ] ASN 44 [ ND2]
Salt Bridges
ARG 21 [ NH2] ASP 30 [ OD2]
Hah1 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
THR 11 31.35 -0.06
CYS 12 53.29 2.01
GLY 13 7.31 0.02
GLY 14 39.71 0.39
CYS 15 36.32 0.90
GLU 17 15.90 0.04
ALA 18 47.19 0.60
SER 20 0.25 -0.00
ARG 21 96.03 -0.99
VAL 22 24.50 0.35
LYS 25 39.21 -0.88
LYS 57 37.60 -0.01
THR 58 30.02 0.11
GLY 59 51.70 0.09
LYS 60 10.00 -0.14
MBD3 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 30 11.66 -0.13
GLY 31 3.54 0.05
ALA 34 17.08 0.59
SER 36 54.14 0.39
ALA 37 19.93 0.80
LEU 39 12.35 0.20
ASN 40 51.81 0.16
GLU 43 12.69 -0.14
ASN 44 15.92 -0.20
ARG 79 7.14 -0.26
ALA 83 52.11 0.34
LEU 84 41.05 0.13
PRO 85 13.51 0.11
PRO 86 136.01 1.62
GLY 87 57.39 0.15
ASN 88 88.68 -0.75
PHE 89 15.17 0.24
LYS 90 27.32 0.44
Hah1 MBD3Hff3
~90° ~90°
A
B C D
 
Figure S5. (A) Illustration of interface residues for Hff3.  Hah1’s interface residues are shown in 
green while MBD3’s interface residues are in purple.  In addition, each protein is rotated ~90° to 
illustrate the interface residues more clearly.  (B) Hah1 interface residues with corresponding 
BSA and ΔGsolv.  (C) Favorable interactions – hydrogen bonds and salt bridges.  (D) MBD3 
interface residues and corresponding BSA and ΔGsolv. 
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MBD3 MBD43ff4
~90° ~90°
Favorable Interactions
MBD3 MBD4
Hydrogen Bonds
SER 36 [ OG ] CYS 136 [ H ]
MBD3 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
GLY 31 3.63 -0.01
HIS 33 0.47 0.00
ALA 34 54.12 2.00
LYS 35 28.30 0.31
SER 36 70.01 0.34
ALA 37 21.97 0.89
LEU 39 39.20 0.63
ASN 40 44.40 0.58
GLU 43 44.78 -0.44
ASN 44 22.23 -0.30
ALA 83 16.68 -0.18
LEU 84 47.52 0.34
PRO 85 8.89 0.11
PRO 86 133.30 1.24
GLY 87 24.10 -0.07
ASN 88 54.24 -0.43
PHE 89 25.33 0.41
MBD4 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ALA 132 10.30 -0.12
GLY 133 19.11 0.29
MET 134 2.06 0.01
THR 135 67.06 0.85
CYS 136 39.68 1.19
ALA 137 1.02 -0.01
SER 138 41.12 0.24
CYS 139 28.34 1.16
HIS 141 3.14 0.02
SER 142 32.42 -0.17
MET 146 78.46 1.53
ILE 147 7.38 0.00
GLN 149 15.16 -0.22
LEU 150 1.50 0.02
ALA 182 1.84 -0.02
GLU 184 12.46 -0.14
ASP 185 38.85 -0.28
MET 186 68.17 0.38
GLY 187 61.05 0.20
PHE 188 53.28 0.68
GLU 189 9.66 0.15
A
B C D
 
Figure S6. (A) Illustration of interface residues for 3ff4.  MBD3’s interface residues are shown 
in purple while MBD4’s interface residues are in orange.  In addition, each protein is rotated 
~90° to illustrate the interface residues more clearly.  (B) MBD3 interface residues with 
corresponding BSA and ΔGsolv.  (C) Favorable interactions – hydrogen bonds.  (D) MBD4 
interface residues and corresponding BSA and ΔGsolv. 
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 S4.2. Head-to-Head Interaction Models.  The head-to-head interaction interfaces are 
illustrated and described for the Hhh4 (Figure S7), Hhh3 (Figure S8), 3hh4 (Figure S9) models.  
Similar to the face-to-face interaction, the head-to-head interface residues are located within the 
two α-helices, but more confined to the loop regions next to the CXXC Cu+-binding motif.  The 
head-to-head interaction models are also summarized in Chapter 4, Section 4.1 and Table 2. 
Hah1 MBD4Hhh4
~90° ~90°
Favorable Interactions
Hah1 MBD4
Hydrogen Bonds
ASP 9 [ O ] THR 135 [ HG1]
Hah1 Interface
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 9 17.23 0.09
MET 10 0.34 0.01
THR 11 65.45 -0.20
CYS 12 57.63 1.91
GLY 13 14.72 -0.07
GLY 14 28.90 0.28
CYS 15 22.03 0.87
GLU 17 11.83 -0.14
ALA 18 25.84 0.41
ARG 21 19.27 -0.22
LEU 35 2.51 0.04
THR 58 20.63 -0.21
GLY 59 15.04 0.03
LYS 60 38.14 -0.78
THR 61 2.14 -0.02
MBD4 Interface
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ALA 122 1.49 0.00
GLY 133 23.49 0.24
MET 134 3.89 -0.03
THR 135 107.12 0.45
CYS 136 65.14 2.14
ALA 137 10.29 0.12
SER 138 41.97 0.13
CYS 139 19.90 0.69
HIS 141 29.38 0.91
SER 142 28.97 0.02
ILE 143 1.96 0.03
MET 186 10.62 0.08
GLY 187 1.89 -0.02
PHE 188 62.68 1.00
A
B C D
 
Figure S7. (A) Illustration of interface residues for Hhh4.  Hah1’s interface residues are shown in 
green while MBD4’s interface residues are in orange.  In addition, each protein is rotated ~90° 
to illustrate the interface residues more clearly.  (B) Hah1 interface residues with corresponding 
BSA and ΔGsolv.  (C) Favorable interactions – hydrogen bonds.  (D) MBD4 interface residues 
and corresponding BSA and ΔGsolv. 
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Hah1 MBD3Hhh3
~90° ~90°
Favorable Interactions
Hah1 MBD3
Salt Bridges
ASP 9 [ OD2] HIS 30 [ NE2]
Hah1 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 9 10.10 -0.09
MET 10 0.31 -0.00
THR 11 28.15 0.04
CYS 12 24.82 0.63
GLY 13 21.06 0.13
GLY 14 12.97 0.16
CYS 15 7.35 0.29
GLU 17 9.13 -0.10
ALA 18 3.69 0.06
ARG 21 3.78 -0.04
LEU 35 20.70 0.32
PRO 36 3.28 0.05
THR 58 6.31 -0.06
GLY 59 6.18 -0.00
LYS 60 9.63 -0.16
THR 61 4.09 -0.05
MBD3 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 30 3.58 -0.03
GLY 31 5.19 0.07
HIS 33 6.72 0.13
ALA 34 22.91 0.58
LYS 35 3.05 0.05
SER 36 16.85 0.08
ALA 37 2.08 0.01
LEU 39 1.88 0.03
ASN 40 19.38 0.04
GLU 43 0.86 -0.01
PRO 85 7.57 0.12
PRO 86 34.00 0.52
ASN 88 27.09 -0.34
PHE 89 9.98 0.16
A
B C D
 
Figure S8. (A) Illustration of interface residues for Hhh3.  Hah1’s interface residues are shown in 
green while MBD3’s interface residues are in purple.  In addition, each protein is rotated ~90° to 
illustrate the interface residues more clearly.  (B) Hah1 interface residues with corresponding 
BSA and ΔGsolv.  (C) Favorable interactions – salt bridges.  (D) MBD3 interface residues and 
corresponding BSA and ΔGsolv. 
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MBD3 MBD43hh4
~90° ~90°
Favorable Interactions
MBD3 MBD4
Hydrogen Bonds
PHE 89 [ H ] CYS 136 [ SG ]
ASP 30 [ O ] THR 135 [ HG1]
MBD3 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 30 3.31 -0.01
GLY 31 14.30 0.20
HIS 33 13.38 0.41
ALA 34 88.48 1.82
LYS 35 21.13 0.22
SER 36 58.42 0.20
ALA 37 5.95 -0.05
LEU 39 4.12 0.07
ASN 40 49.85 0.18
ILE 41 0.17 0.00
GLU 43 1.70 -0.02
LEU 84 1.39 0.01
PRO 85 12.53 0.20
PRO 86 26.54 0.41
ASN 88 79.24 -0.88
PHE 89 41.85 0.67
MBD4 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ALA 132 21.33 0.00
GLY 133 9.64 0.14
MET 134 9.82 -0.07
THR 135 116.94 0.38
CYS 136 89.90 3.32
ALA 137 52.07 0.76
SER 138 49.64 0.12
CYS 139 15.53 0.59
HIS 141 12.50 0.70
SER 142 20.30 -0.03
LEU 160 16.05 0.26
MET 186 15.54 0.02
GLY 187 20.91 0.01
PHE 188 61.04 0.98
GLU 189 2.95 -0.03
A
B C D
 
Figure S9. (A) Illustration of interface residues for 3hh4.  MBD3’s interface residues are shown 
in purple while MBD4’s interface residues are in orange.  In addition, each protein is rotated 
~90° to illustrate the interface residues more clearly.  (B) MBD3 interface residues with 
corresponding BSA and ΔGsolv.  (C) Favorable interactions – hydrogen bonds.  (D) MBD4 
interface residues and corresponding BSA and ΔGsolv. 
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 S4.3. Face-to-Back Interaction Models.  The face-to-back interaction interfaces are 
illustrated and described for the Hfb4 (Figure S10), Hfb3 (Figure S11), 3fb4 (Figure S12) models.  
The “face” interface residues are in a region similar to those observed in the face-to-face 
interactions, while the “back” interface residues are found in the β-sheet regions next to the N-
terminus.  The face-to-back interaction models are also summarized in Chapter 4, Section 4.1 
and Table 2. 
Hah1 MBD4Hfb4
~90° ~90°
Favorable Interactions
Hah1 MBD4
Hydrogen Bonds
CYS 15 [ SG ] SER 124 [ O ]
CYS 15 [ SG ] SER 124 [ OG ]
THR 11 [ O ] THR 123 [ N ]
Hah1 Interface
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 9 18.30 -0.06
THR 11 55.16 -0.03
CYS 12 29.13 0.92
GLY 14 1.61 0.03
CYS 15 22.33 0.90
ALA 18 5.42 0.09
LYS 56 3.52 -0.04
LYS 57 5.84 -0.07
THR 58 17.05 -0.19
GLY 59 58.37 0.07
LYS 60 35.73 -0.55
THR 61 9.43 -0.08
MBD4 Interface
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
THR 123 45.95 0.30
SER 124 81.49 2.21
SER 125 0.50 0.01
THR 126 23.92 0.00
GLN 154 45.81 -0.47
GLN 155 65.37 -0.82
THR 166 6.80 0.11
LEU 168 34.00 0.54
PRO 171 0.70 0.01
A
B C D
 
Figure S10. (A) Illustration of interface residues for Hfb4.  Hah1’s interface residues are shown 
in green while MBD4’s interface residues are in orange.  In addition, each protein is rotated 
~90° to illustrate the interface residues more clearly.  (B) Hah1 interface residues with 
corresponding BSA and ΔGsolv.  (C) Favorable interactions – hydrogen bonds.  (D) MBD4 
interface residues and corresponding BSA and ΔGsolv. 
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MBD3 Hah1Hbf3
~90° ~90°
Hah1 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
PRO 2 23.40 0.14
LYS 3 45.32 -0.61
GLY 28 1.58 -0.00
VAL 29 0.79 0.01
LYS 30 130.94 1.05
TYR 31 15.85 -0.05
ASP 32 20.95 0.12
SER 41 1.58 0.02
ILE 42 0.34 0.01
GLU 43 68.53 -0.37
SER 44 6.75 0.08
GLU 45 3.58 0.06
Favorable Interactions
MBD3 Hah1
Hydrogen Bonds
LEU 84 [ O ] LYS 3 [ HZ2]
GLY 87 [ O ] TYR 31 [ H ]
MBD3 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 30 0.49 -0.01
ALA 34 3.79 0.15
SER 36 6.99 -0.00
ALA 37 5.93 0.24
ASN 40 5.51 -0.09
GLU 82 3.82 0.02
ALA 83 7.91 0.03
LEU 84 17.90 -0.20
PRO 85 13.14 0.11
PRO 86 126.32 1.51
GLY 87 55.80 0.06
ASN 88 72.11 -0.47
PHE 89 17.75 0.25
LYS 90 11.35 0.18
A
B C D
 
Figure S11. (A) Illustration of interface residues for Hbf3.  Hah1’s interface residues are shown 
in green while MBD3’s interface residues are in orange.  In addition, each protein is rotated 
~90° to illustrate the interface residues more clearly.  (B) MBD3 interface residues with 
corresponding BSA and ΔGsolv.  (C) Favorable interactions – hydrogen bonds.  (D) Hah1 
interface residues and corresponding BSA and ΔGsolv. 
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Favorable Interactions
MBD3 MBD4
Hydrogen Bonds
GLY 31 [ O ] SER 124 [ SG ]
ASP 30 [ OD2] GLN 154 [ NE2]
ASN 88 [ O ] GLN 154 [ NE2]
GLU 82 [ O ] GLN 155 [ NE2]
ASN 88 [ ND2] SER 125 [ O ]
MBD4 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
THR 123 43.87 0.25
SER 124 75.22 1.89
SER 125 2.68 0.04
THR 126 37.99 0.14
GLN 154 45.33 -0.39
GLN 155 86.71 -0.91
ILE 156 0.49 0.01
SER 157 6.49 0.10
THR 166 28.01 0.12
VAL 167 2.39 0.04
LEU 168 45.82 0.72
MBD3 Interface Residues
Residue BSA (Å2)
-ΔGsolv
(kcal/mol)
ASP 30 10.50 -0.12
GLY 31 17.99 0.20
HIS 33 6.46 0.10
ALA 34 48.69 1.91
SER 36 10.26 -0.02
ALA 37 18.60 0.76
ASN 40 9.62 -0.10
GLU 82 9.90 0.02
ALA 83 2.15 -0.02
LEU 84 3.90 -0.04
PRO 85 14.06 0.12
PRO 86 117.00 1.25
GLY 87 58.51 0.43
ASN 88 117.40 -0.76
PHE 89 22.80 0.35
LYS 90 9.37 | 0.15
MBD3 3fb4 MBD4
~90° ~90°
A
B C D
 
Figure S12. (A) Illustration of interface residues for 3fb4.  MBD3’s interface residues are shown 
in purple while MBD4’s interface residues are in orange.  In addition, each protein is rotated 
~90° to illustrate the interface residues more clearly.  (B) MBD3 interface residues with 
corresponding BSA and ΔGsolv.  (C) Favorable interactions – hydrogen bonds.  (D) MBD4 
interface residues and corresponding BSA and ΔGsolv. 
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S5. Details of Molecular Dynamics Simulation 
 All molecular dynamics simulations were performed by Linghao Zhong (Pennsylvania 
State University, Mont Alto, PA). The simulations were carried out on four possible models of 
the Hah1-MBD4 complex (Hff4, Hfb4, Hbf4, and Hhh4). All calculations were performed with 
CHARMM104 using the CHARMM27105 protein force field. For each model, the complex was 
placed in the center of a TIP3P106 periodic water box. A minimum of 10 Å solvation shell was 
allowed for each protein atom, resulting in a box of about 80 × 50 × 50 Å3 in size. Five Cl and 
13 Na+ ions were added to neutralize the system, so particle mesh Ewald could be used for the 
long-range electrostatics.107 The cutoff for non-bonded interactions was set to be 12 Å. The 
SHAKE algorithm108 was applied to fix lengths for all bonds with hydrogen attached, and a 2-fs 
step size was used for the integration. The system was first heated up stepwise at 100 K, 200 K 
and 300 K, each for 20 ps, followed by 40 ps of equilibration time. To collect the production 
trajectory, the system was integrated as a microcanonical ensemble (NVE) at 300 K with 
periodic boundary conditions (PBC). For the Hff4, Hfb4, and Hhh4 models, the production 
trajectories were collected for 10 ns. Only 1.5 ns of production were collected for the Hbf4 model 
due to the rapid dissociation. 
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